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 ABSTRACT 
Gastric cancer represents the fifth most common cancer and the third leading cause 
of cancer death over both sexes worldwide, with almost 1 million cases and over 700 
000 deaths estimated in 2012. The presence of Helicobacter Pylori is a key 
determinant of gastric cancer. However, other factors, including familial, genetic, 
environmental and social characteristics appear to also have a role in the etiology of 
this disease. Tobacco smoking has been associated with increased risk of morbidity 
and mortality from many diseases and for gastric cancer. Various epidemiologic 
consortia have been established on several cancers but not yet on gastric cancer. A 
pooled-analysis of worldwide case-control studies may allow to investigate indebt 
gastric cancer etiology. Particularly, this large dataset will allow us to better 
investigate life style characteristics including tobacco smoking, in relation to gastric 
cancer. The Stomach cancer Pooling (StoP) Project is an international epidemiological 
consortium. The inclusion criteria for study participation are: a case-control study 
design (including nested case-control analyses derived from cohort study) and an 
inclusion of at least 80 cases of gastric cancer (including both cardia and non-cardia 
location). The aim of my project is to conduct a pooled analysis on data from already 
available international studies, on the role of tobacco smoking in the etiology of 
gastric cancer in particular, the number of cigarettes per day and the duration of 
smoking, using adequate statistical approaches. 
During the first year of the PhD program, my project was focused on the two-stage 
analysis.  This method is used to analyze meta-analysis and could be applicable in a 
case of pooled case-control analysis. The first step of the method consists in calculate 
adjusted study-specific odds ratios (OR) in order to overcome differences across 
studies in terms of design or population. The second step consists in summarize these 
study-specific risks using meta-analytic methods which take into account the 
heterogeneity across studies. During my second year of PhD program, I studied 
various statistical methods regarding the analysis of non-linear continuous variables. 
In addition to transform continuous variables in category, I considered more flexible 
approaches including fractional polynomials. During my third year of PhD program, I 
focused my research on a way to adapt these latest methods to the analysis of pooled 
case-control studies. In particular I chose to use factional polynomials in a two-stage 
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method due to their simple interpretation and also because their estimates can be easily 
pooled through a two-stage analysis. 
The first step analysis is to perform a fractional polynomial for each study. For 
each value of the power term (or couple of power terms for the second-order fractional 
polynomials), the second stage of the model is performed. The pooled dose-response 
relationship is estimated according to a bivariate random-effects model. The estimate 
of the trend components could be obtained using restricted maximum likelihood 
(REML) or maximum likelihood (ML) estimation. The  second-stage model is fitted to 
the data considering each combination of the power terms. The best model, denoted by 
the optimal power combination is defined as the one minimizing the deviance or the 
Akaike Information Criterion (AIC), a penalized likelihood which takes into account 
the number of parameter. 
We analyzed data on 21 studies including 10,040 cases and 25,602 controls. To 
investigate the relationship between tobacco smoking and gastric cancer risk, we first 
used a classical method, building categories of smokers 1) in terms of quantity; “never 
smokers”, “<10 cigarettes per day”, “Between 11 to 20 cigarettes per day”, “>20 
cigarettes per day” and 2) in terms of smoking duration; “never smokers”, “<10 year 
of smoking”, “Between 11 and 30 years of smoking”, “>30 years of smoking”. We 
analyzed these variable with a two-stage method. This risk significantly increase with 
the number of cigarettes per day to reach an OR of 1.29 (95% CI 1.06-1.57 )for 
smokers of more than 20 cigarettes and, with duration to reach an OR of 1.32 (95% CI 
1.17-1.49) for smokers smoking for more than 30 years compared to never smokers. 
These effects of increasing risk are confirmed by different statistical models of 
analysis  including linear model and fractional polynomials, considering the number of 
cigarettes per day and the duration as a continuous variable.  
Results from our analysis confirm that there is an association between cigarette 
smoking and gastric cancer risk. This risk increases with the number of cigarettes and 
the duration of smoking. These effects of increasing risk are confirmed by different 
statistical models of analysis including linear models and fractional polynomials, 
considering the number of cigarettes per day and the duration as continuous variables. 
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To our knowledge this is the first study using fractional polynomials through a 
two-stage random effect methods for pooled case-control studies. Through this method 
we were able to take into account study-specific adjustment variables and 
heterogeneity across studies thanks to mixed effect modeling. Categorization has the 
advantage of a simple epidemiologic interpretation and presentation result. However it 
assumes that the relationship between the risk of disease and the exposure is flat 
within intervals and also that there is a discontinuity in response when a category 
cutpoint is crossed, which is unlikely realistic. Considering exposure variables may 
avoid these limitations. The relationship between cigarette smoking and gastric cancer 
risk may be discerned from the categorical analysis, but the analysis of the variable in 
continuous through polynomials brought additional information in particular to 
understand the possible threshold and possible changes in slopes.  
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I. INTRODUCTION AND BACKGROUND 
 
Gastric cancer represents the fifth most common cancer and the third leading 
cause of cancer death over both sexes worldwide, with almost 1 million cases and over 
700,000 deaths estimated in 2012[1]. Gastric cancer incidence rates vary widely across 
different regions of the world and between men and women. The majority of gastric 
cancers were reported in developing countries (about 700,000 cases and 550,000 
deaths). The highest age-standardized incidence rates (ASR) for gastric cancer were 
found in Eastern Asia (24.2 per 100 000), Central and Eastern Europe  (13.5 per 100 
000) and South America (10.3 per 100 000) and the lowest in North-America and in 
Africa. Comparing genders, rates are 2- to 3-folds higher in men than women 
(worldwide ASR incidence respectively 17.4 and 7.5 per 100 000 in 2012) [1]. 
 
 
Figure 1: Estimated stomach cancer incidence worldwide in 2012 in men 
 (Source Globocan 2012 [1]) 
- 12 - 
 
 
Figure 2: Estimated stomach cancer incidence worldwide in 2012 in women  
(Source Globocan 2012 [1]) 
 
Over the recent decades, gastric cancer mortality rates steadily declined 
worldwide [2] and although the reasons for these declines are not fully understood. 
Almost certainly, the reasons of these declines include a more varied and affluent diet 
and a better food, including refrigeration as well as the control of helicobacter pylori 
(HP) infection, a key determinant of gastric cancer [3].  
Other factors appear to have a role in the etiology of the disease [4] some are not 
modifiable such as age and sex whereas others, such as smoking and HP infection, 
potentially are and prevention can be made in that direction. 
Regarding the effect of diet, in 2007, the World Cancer Research Fund and the 
American Institute for Cancer Research (WCRF/AICR) concluded that non-starchy 
vegetables, allium vegetables and fruit probably protect against cancer, and that salt 
including salted and salty food increases the risk of gastric cancer [5]. A meta-analysis 
of studies on dietary patterns (defined a priori¸ i.e., on the basis of specific data under 
consideration) found an about two-fold difference in gastric cancer risk between a 
dietary pattern characterized rich in fruit and vegetables and an another one 
characterized rich in starchy foods, meat and fats [6]. The detrimental effects of 
processed meat and grilled animal has also been suggested by the WCRF/AICR [5]. 
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Tobacco smoking is an established risk factor of many cancers and chronic 
diseases. In particular, in the last years, several studies confirmed a positive 
association between smoking status and gastric cancer [7]. Two recent meta-analyses 
considering 32 cohort studies [8] and 46 case-control studies [9] showed a significant 
increasing risk of gastric cancer of 53% and 69%, respectively, in current smokers 
compared to never smokers. A recent study estimated the worldwide burden of gastric 
cancer attributable to tobacco smoking in 2012, and found a median of 19.5% for men 
and 3.0% for women [10]. 
Risk of gastric cancer was also reported to increase with increasing doses and 
duration of cigarette smoking. The meta-analysis of cohort studies [8] showed an 
increasing trend in risk with a relative risk (RR) varying from 1.3 for the lowest doses, 
to 1.7 for 30 smoking cigarettes per day. A significant trend in gastric cancer risk with 
increasing duration was reported in the European Investigation into Cancer and 
Nutrition (EPIC) [11] and the Multiethnic Cohort (MEC) study [12]. Similarly, a 
recent meta-analysis considering 10 studies on gastric cardia adenocarcinoma reported 
an over two-fold risk for smokers of more than 40 years compared to never smokers 
[13]. 
Risk has been generally found to be lower in former smokers compared to current 
smokers and seems to decrease with increasing years since stopping smoking, 
although none found statistically significant dose-response relationships [7, 11, 14-17]. 
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Figure 3: Joinpoint Analysis for gastric cancer in selected countries at all ages (men and 
women), 1980-2005 (when available). Men ♂―♂ ; Women  ♀―♀ 
 (Source Bertuccio et al. International Journal of Cancer 2009 [2]) 
 
Various consortia of epidemiological studies have been established during the last 
two decades, to pool and analyze data on risk factors for breast, ovarian, head and 
neck, pancreatic, thyroid and other neoplasms. These allowed to identify, and  to better 
quantify the role of important risk factors for various cancers [18, 19]. Because of 
larger sample sizes, it also offers to consider uncommon exposure, rare diseases, and 
lead subgroup analyses with greater statistical power than is possible in individual 
studies (ref Smith-Warner). However, a similar project has not yet been conducted for 
gastric cancer. A lot of large case-control studies on this neoplasm have been 
conducted over the years, and a concerted strategy for the joint analysis of these 
investigations may allow new insights on gastric cancer etiology. 
The aim of my PhD was to work on a consortium of case-control studies on 
gastric cancer, helping in the management of the project (creation of the core 
variables, harmonization of the datasets and participation of international meeting) and 
conducting analyses on risk factors using adequate statistical approaches. 
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During my first year of PhD, I studied the two-stage method. This method is often 
used to analyze meta-analysis and could be applicable in a case of pooled case-control 
analysis [20, 21]. The first step of the method consists in calculate adjusted study-
specific odds ratios (OR) in order to overcome differences across studies in terms of 
design or population. The second step consists in summarize these study-specific risks 
using meta-analytic methods which take into account the heterogeneity across studies. 
During my second year of PhD, I studied different approaches to analyze continuous 
risk variables. The standard approach is to categorize the exposure but it exists other 
methods avoiding cutpoints including non parametrical methods (such as generalized 
additive models) or parametrical methods using for example fractional polynomial 
regressions or regression splines. 
During my third year of PhD, I focused my research on a way to adapt these latest 
methods to the analysis of pooled case-control studies. In particular I chose to use 
factional polynomials in a two-stage method due to their simple interpretation and also 
because their estimates can be easily pooled through a two-stage analysis. 
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II. STATISTICAL APPROACH FOR STUDYING CONTINUOUS RISK 
FACTORS IN A CONSORTIUM OF CASE-CONTROL STUDIES 
 
In these pooled data analyses, we will study the effect of risk factors on the 
occurrence of gastric cancer. The standard approach for the statistical analysis is to 
conduct aggregate analyses, using data as a unique dataset and to estimate odds ratio 
and corresponding 95 % confidence interval using multivariable logistic regression 
adjusted for the variable identifying the study and other potential confounding 
variables.  
However, in this case, some problems arise that the aggregate analyses cannot take 
into account. 
 
In fact, there is a problem of correlated or clustered data: 
- The binary outcome variable is observed in a group or a cluster 
- Each members of the group is correlated with the other members of the same group 
- Each group could have its own specific variables 
- The variability across groups is high 
 
Not grouped data          Grouped data  
 
 
To take into account this information, one of the approaches that could be used is the 
two-stage analysis method. This method is often used to analyze meta-analysis and 
could be applicable in a case of pooled case-control analysis [20, 21]. 
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The two-stage method is an approach that consists of estimating the effect of a 
uniformly-defined exposure variable within each study and then combining these 
estimates across studies. 
 
1. The two-stage analysis 
 
1.1. The logistic regression model 
 
We consider k studies (k=1,…, K). The first step of the two-stage method is to 
perform a logistic regression model for each study. The logistic regression describing 
the effect of the exposure X on the disease, that is characterized by the presence (Y=1) 
or the absence (Y=0), adjusting for Z, a confounder that may differ across studies. The 
model is written as, 
 
Logit (P(Y = 1 | X, Z) = αjk + βkXik + γkZik          (1) 
 
where   j: stratum of study {j=1,…Sk} 
k: the identification of the study {k=1,…,K} 
i: individual cases and controls {i=1,…njk} 
α: intercept 
β: the parameter estimated for X 
γ: the parameter estimated for Z 
 
The exposure X is uniformly defined across studies. However, the confounders Zk may 
be specific to a particular study and may vary in definition across studies. To simplify 
we assume only one confounder per study but this is easily generalized to more. 
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The logistic regression can be performed with the SAS software (SAS Institute Inc, 
Cary, NC) using the PROC LOGISTIC procedure. 
 
1.2. Test of homogeneity 
 
To choose the adequate model of the second step of the two-stage model, a test of 
homogeneity between the studies is required. It allows to evaluate the consistency of 
exposure effects across the studies. 
The hypothesis of the test of homogeneity is: 
    H0: β1=β2=…=βK 
    H1: At least one of the βk is different 
 
Under the null hypothesis t the test statistic is defined by: 
Q =	∑ 	 (	
 −		
)                    (2) 
where   	
 = ∑ 	∑ 	    and   		 = .  
In particular, 	
 is the estimation of the pooled exposure log-odds ratio and σk2 
represents the within-study variation of the βk. 
The Q test statistic follows a Chi2 distribution with k-1 degrees of freedom, Q ~ 
	 .    
When there is homogeneity of exposure effects across studies, we can assume that the 
variance across studies   is null ( = 0)	and exposure effects can be estimated 
through a fixed effect model. 
A high value of Q indicates a high variability across studies and when the null 
hypothesis is rejected, it means that exposure effects are not homogeneous between 
studies; in this case, the pooled-exposure effect is generally estimated using a random 
effect model.  
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1.3. The fixed effect model 
 
The fixed effect model is generally used when the exposure-effect is not different 
across studies.  The second stage of the model is defined by  
βk	=	β	+	ek	 with		βk	~	N	(β,	%)	and	ek	~	N	(0,	%). 
Thus, the pooled-exposure effect is a simple weighted average of the βk 
	 = ∑ 		 ∑ 	   with weights 		 equal to the inverse of the variance,    		 =*+,() = . 
The variance of the pooled effect β is equal to  -./(	) = 0∑ 	 1 . 
The sample estimates of the above quantities are:  
	
 = ∑ 	∑ 	     with  	 =                         (3) 
 
1.4. The random effect model 
 
The random effect model is generally used when the exposure effect is different 
across studies. This supposes that the pooled-exposure effect  βk varies across studies 
around the real parameter 	 with a variance  according to the second-stage model: 
βk	=	β	+	bk	+	ek  with	βk	~	N	(β,	% + )        (4)
     
  
where   β is the pooled exposure log-odds ratio 
  bk are random effects with bk ~ N (0, ) 
- 20 - 
 
  represents the variability of the study-specific exposure effects βk 
    
about the population mean β. 
  ek are independent errors with ek ~ N (0, σk2) 
  σk2 represents the within-study variation of the βk 
The estimation of the pooled-exposure effect β is the weighted average of the βk , 
weighted by the inverse marginal variance of the 	
 as follows: 
	
 = ∑ 3	∑ 3	     with  w5	 = 6789          
     (5) 
and     var(	
) = ∑ 3          
   
 
To compute the estimation of the pooled-exposure effect, an estimate of the random 
effects variance is required. Two methods are frequently used: the moment 
estimation and the pseudo-maximum likelihood. 
The variance θ2 of a random effects model is a measure of the heterogeneity across 
studies (a fix effects model is a particular case where θ2 = 0) 
 
- The moment estimation of θ2   
The moment method compares the observed and expected values of the Q statistic 
[20]. 
Q = ∑ 	 (	
 −		
) 
Thus, E(Q) =  E [ ∑ 	 (	
 −		
)]  
=  ∑ 	E( 	
5) − ∑ 	E( 	
)  
= k – 1 + θ2 	[	∑ 3	<3=1 − ∑ ∑  	] 
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= Q 
The estimation of  θ2 can be derived resolving the equation above and 
    if    > 0   =   
              0   if   ≤	0 
 
Where      =	 @	−	(3−1)∑ 3−	A∑ 32<3=1 ∑ 3<3=1C D<3=1       (6) 
Where Q and wk are described above. This estimator is unbiased and non-iterative. 
Since the moment estimation of θ2 and the calculation of Q and 	
   require matrix 
calculations, the SAS procedure PROC IML can be used. 
 
- The pseudo-maximum likelihood estimation of θ2 
The approach used to estimate the variance θ2 by the maximum likelihood is the 
restricted maximum likelihood  (REML) method. 
The estimator REML of E8 	is: 
(E8) =	E	(∑ F	3−		(r)H2<3=1 I%32+θ(r)2 K
−2
∑ I%32+θ(r)2 K−1<3=1 )      (7) 
  
Where 	
(,) is recomputed at the rth iteration from (5) 
 (L) =  	∑ [0	
 −		
1 −	%M] is an initial estimate of θ2 
 	
(L) =	∑  NO7∑  ⁄O7 	, the weighted average of  the study-specific 	
 is an initial 
estimate of β  
To obtain 	
, on first computes 	
(L) and (L)  and then iterates between computing (E)  
and 	
(,) until convergence. 
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These estimations can be performed with the SAS procedure PROC MIXED. 
 
Among all risk factors considered in the StoP project, some variables can be 
continuous. The standard approach to model continuous risk variables is 1) to 
categorize the exposure into two or more categories, creating dummy and then 
calculating the effects using one category as reference group or 2) using a linear model 
to describe the relation between exposure and effect. These methods present the 
advantage of a simple epidemiologic interpretation but include a loss of statistical 
efficiency and important errors in particular if the measured relation is not linear.[22] 
The approaches to overcome limitations related to these methods can be non-
parametric (such as generalized additive models) or parametric, i.e. fractional 
polynomial regressions or regression splines.   
 
During the third year of PhD, I decided to put an emphasis on the analysis of the 
effect exposure variable measured on a continuous scale through a two-stage analysis 
using as reference a methods developed on meta-analysis of published data [23]. 
I focused this analysis on fractional polynomials because in the epidemiological 
context it is a simple but flexible approach. I contrasted it with the traditional analysis 
using categories.  
 
 
 
 
 
2. Fractional polynomials through a two-stage analysis: first step 
 
We consider k studies (k=1,…, K). The first step of the two-stage method is to 
perform a logistic regression using fractional polynomials for each study.  
Fractional polynomials were developed by Royston and Altman [24] to look for 
nonlinearity. They are an extension of polynomials where the exponents can be 
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negatives and/or integer and are usually chosen from the predefined set P={-2;-1;-
0.5;0;0.5;1;2;3}.  
 
2.1. First order fractional polynomials 
 
The polynomial is characterized by  
 
FP5 =	S 	+		TU + VW 
 
where   X the exposition variable 
  Z the confounders 
  k: the identification of the study {k=1,…, K} 
α: intercept 
γ: the parameter estimated for Z 
β: the parameter estimated for X 
p the power term, p ∈ P={-2;-1;-0.5;0;0.5;1;2;3} with 
XZ =	 [ XZ											if	p ≠ 0ln X 										if	p = 0 
For example,  
p1=2 the model is FP1= β0 + β1 X2 
p1= 0 the model is replace by FP1= β0 + β1 lnX 
Hence, there are 8 different first-order fractional polynomials (FP1) models. 
For p=1, the linear model is generated. From the predefined set P, some important 
transformations are generated such as the inverse (p=-1), the squared root (p=0.5), the 
logarithm (p=0) and the quadratic (p=2) transformation. 
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2.2. Second order polynomials 
 
Second order polynomials are defined as follows  
 
FPa5 =	S 	+ 	b	cTUdec 	+ VW 
 
where   m the degree of the fractional polynomial j=1…m 
k: the identification of the study {k=1,…, K} 
α: intercept 
β: the parameter estimated for X 
X the exposition variable 
γ: the parameter estimated for Z 
Z the confounders 
  pj the power terms, pj ∈ P={-2;-1;-0.5;0;0.5;1;2;3} with 
XZf = g XZ	f											if	p ≠ 0			ln X 										if	p = 0							XZ	f ln X 			if	pf = pf	
 
For example,  
if m=2, p1=1 and p2=2 the model is FP2= β0 + β1 X + β2 X2 
if m=2 and p1= p2 the model is replace by FP2= β0 + β1 Xp + β2 (Xp ln X) 
 
Hence, there are 36 different second order fractional polynomials (FP2) models. In 
practice, it has been observed that it is rarely necessary to consider degrees higher than 
2 so we considered the second-order fractional polynomial for the rest of this report.  
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Second order fractional polynomials can be monotonic or unimodal (i.e. with a 
maximum or a minimum point for some positive value of X). The value of X for the 
minimum or maximum point of the function, can be derived from the formulae given 
in the Table 1.  
 
Table 1. Minimum or maximum point for second order fractional polynomials based on the 
power (p1 ; p2) values and the model estimates  (β1 ; β2). r= - β1/β2. 
Powers value p1=0 p1≠0 
p2=0 (p2≠p1) ∄ (/i)/U 
p2≠0 (p2≠p1) (//i)/U (/i/i)/(UU) 
p2=p1 exp	(//2) exp	(/ − 1/i) 
 
Models generated with the second-order fractional polynomial technical are ranging 
from U-shaped to J-shaped relationships 
 
Figure 4: Some examples of curve shape with second-degree fraction polynomials  
with p1=-2 and p2 varying from -2 to 1.  
 
The confounders Zk may be specific to a particular study and may vary in definition 
across studies. To simplify, then  we assume only one confounder per study but this is 
easily generalized to more. 
(-2, 1) (-2, 2)
(-2, -2) (-2, -1)
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3. Fractional polynomials through a two-stage analysis: second step  
 
For each value of the power term (or couple of power terms for the second-order 
fractional polynomials), the second stage of the model is performed.  
The pooled dose-response relationship is estimated accordingly to the bivariate 
random-effects model: 
I		K = IllK + ImmK + InnK 
I		K	~	o pIllK , σ5 + r 
 
Where  µ1 and µ2 are the pooled trend component 
σ5 is the within study variance matrix of the kth study  
θ2 is the between-studies variance matrix that has to be estimated:	
 	= 	 I s./(l) tus(l, l)tus(l, l) s./(l) K 
e1 and e2 are independent error with  FvvH	~	o(0, σ5) 
 
The estimate µ=(µ1, µ2) of the trend component µ1 and µ2 could be obtained using 
restricted maximum likelihood (REML) or maximum likelihood (ML) estimation [25].  
The  second stage model is fitted to the data considering each combination of the 
power terms. The best model, denoted by the optimal power combination (p1, p2) is 
defined as the one minimizing the deviance or the Akaike Information Criterion 
(AIC), a penalized likelihood which takes into account the number of parameter . 
Finally the expected log(OR) at exposure level x can be estimated from the optimal 
model as 
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log(yz) = 	l{U + l{U 
with a 95% confidence interval equal to log(yz) ± 1.96	tus(l)T 
where  T = ({U , {U) the power transformation for the assigned dose x 
tX   is the transpose of X 
tus(l) = (∑ (s + ) )   
where T is the estimated of θ2, the between-studies variance matrix 
vj is the estimated of σf, the within study variance matrix of the jth 
study 
 
These estimations can be performed with the SAS procedure PROC MIXED. 
 
As a strategy for selecting the best model the following selection procedure is 
proposed [26, 27] 
1. Overall association 
Test the best FP2 model against the null model using 4 degrees of freedom. If the 
test is not significant, it means that the effect of the exposure is not significant. 
The analysis can stop at this point. 
2. Evidence for non-linearity 
Test the best FP2 model against the straight line using 3 degrees of freedom. If the 
test is not significant, it means that the relationship between the risk of disease and 
the exposure, is linear. The final model is a straight line. 
3. Test the best FP2 against the best FP1 using 2 degrees of freedom. If the test is 
not significant, the final model is FP1, otherwise the final model is FP2. 
 
We elaborated a SAS macro for both first-order and second order polynomial through 
a two-stage analysis. 
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III. DESCRIPTION OF THE STOP PROJECT 
 
The Stomach cancer Pooling (StoP) Project is an international epidemiological 
consortium. The inclusion criteria for study participation are: a case-control study 
design (including nested case-control analyses derived from cohort study) and an 
inclusion of at least 80 cases of gastric cancer (including both cardia and non-cardia 
location).  
To date, 34 studies from 14 countries agreed to participate (2 from Brazil, 1 from 
Canada, 3 from Mexico, 2 from USA, from Greece, 4 from Italy, 1 from Portugal, 1 
from Russia, 2 from Spain, 3 from Sweden, 1 from Latvia, 4 from China, 3 from Iran, 
3 from Japan), for a total of around 13,000 cases and 31,500 controls, and contacts are 
ongoing with investigators involved in 6 other studies (1 from Finland, 1 from Poland 
and 3 from the USA), for potential inclusion of these investigations during the next 
months (summary information on preliminary data available Table 2). 
 
1. Characteristics of each study 
 
Table 1 describe the main characteristics of each study. 
 
The study 7 from Canada (Principal investigator, PI: K. Johnson) [28] was conducted 
in 8 provinces (British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Prince 
Edward Island, Nova Scotia and Newfoundland) between 1994 and 1997. It included 
1182 cases (379 women and 803 men) and 5039 controls (2492 women and 2547 
women) matched with cases on age and sex. 
 
The study 14 MSKCC (Memorial Sloan Kettering Cancer Center) (PI: ZF Zhang) [29] 
was conducted in New-York between November 1992 and November 1994. It 
included 134 incident cases (99 men, 35 women) and 132 controls (62 men, 70 
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women) classified cancer-free after endoscopic examination in the same endoscopy 
unit of the cases at the MSKCC. 
 
The study 16 from New-York, USA (PI: J Muscat) (unpublished data) was conducted 
between 1980 and 1990 on 87 (78 men, 9 women) incident cases and 261 hospital-
based controls matched to cases on age and sex.   
 
The study 6 from the greater Athens area, Greece (PI: D Trichopoulos) [30] was 
conducted between May 1981 and June 1984, on 110 incident cases (57 men, 53 
women, mean age 64.5, range 34-85) with histologically confirmed adenocarcinoma 
of stomach and 100 hospital-based  controls (49 men, 51 women, mean age 59.8, 
range 34-84).  
 
The study 1 from the greater Milan area, Italy (PI: C La Vecchia) [31] was conducted 
between 1985 and 1997 on 769 incident, histologically confirmed cases of stomach 
cancer (469 men, 300 women, median age 61 years, range 19-80 years) and 2081 
controls (1220 men, 861 women, median age 55 years, range 19-80 years). Controls 
were subjects admitted to the same network of hospitals as cases. 
 
The study 3 from the greater Milan area, Italy (PI: E Negri) [32] was conducted 
between 1997 and 2007 on 230 incident cases of gastric cancer (143 men, 87 women; 
median age 63 years, range 22–80 years) and 547 controls (286 men, 261 women, 
median age 63 years, range 22–80 years), frequency-matched with cases by age and 
sex. Controls were subjects admitted to the same network of hospitals as cases. 
 
The study 4 from Rome, Italy (PI: S Boccia) [33] was conducted from November 1999 
to February 2005 on 76 cases (37 men, 39 women, mean age 66.1, range 32-89) and 
260 control controls (145 men, 115 women, mean age 63.8, range 30-91). Controls 
were selected from the same hospital as cases and matched to cases on age and sex. 
- 30 - 
 
 
The study 5 from 4 areas in Italy (PI: D Palli) [34] involved 2 areas with high death 
rates for gastric cancer (1: Forlì, Cremona and Imola and 2: Florence and Siena) and 2 
areas with low death rates for gastric cancer (3: Genoa and 4: Cagliari). It included 
1229 cases (640 men, 376 women, median age 65) and 1159 controls (705 men, 454 
women) matched with cases on age and sex. 
 
The study 17 from Porto, Portugal (PI: N Lunet) [35] was conducted between 1999 
and 2006 and included 568 cases (353 men, 215 women, age range 18-92) and 1585 
controls. Cases and controls were frequency matched on age and sex. Controls were 
part of a representative sample of the adult population of Porto. 
 
The study 9 from Moscow, Russia (PI: D Zaridze) [36] was conducted between 1996 
and 1997 on 448 cases (248 men, 200 women) and 610 hospital-based controls (292 
men, 318 women). 
 
The study 21from Spain (PI: N Aragones) (unpublished data) was conducted in 
Asturias, Barcelona, Cantabria, Granada, Huelva, Leòn, Madrid, Murcia, Navarra and 
Valencia, between 2008 and 2012. Around 400 incident cases and 1800 controls were 
included and were matched on age, gender and recruitment area. Controls were 
selected in the general population residing in the catchment areas of the hospitals 
where cases were recruited. The final dataset of the study is under preparation, 
therefore the precise number of included subjects is not yet available. 
The other study from Spain, study 23, (PI: J. Vioque Lopez) [37] was conducted 
between January 1995 and March 1999 in 9 hospitals in Alicante and Valencia on 399 
incident histological cases (265 men, 134 women) and 455 hospital-based controls 
(285 men, 170 women) frequency matched by sex, axe and province of residence. 
The study 22 from Sweden (PI: O Nyren) [38] was conducted from 1989 to 1995 on 
514 cases (348 men, 166 women) and 1164 controls (779 men, 385 women). Controls 
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were randomly selected from population registers and were frequency matched to 
cases on age and sex. 
 
The two other studies 18 and 20 from Sweden (PI: N Orsini) (unpublished data) was 
conducted in two counties of central Sweden, Vastmanland and Uppsala on women 
only for the first one and  Vastmanland and Orebro on men only for the second one.  
They are nested case-control studies, derived from the Swedish mammography cohort 
(93 cases and 372 controls) and the cohort of Swedish men studies  (176 cases and 704 
controls). 
 
The study 2 from Harbin, China (PI: J Hu) [39] was conducted from March 1987 to 
May 1989 on 266 newly diagnosed and histologically confirmed stomach cancer 
patients (206 Men and 60 women, median age 57 years, range 23-80). Controls were 
533 patients (412 men, 121 women, median age 57, range 22-79) admitted to the same 
hospitals for non-neoplastic and non-gastric diseases. Cases were not individually 
matched to controls, but were well comparable by age and sex.  
 
The study 8 from Taixing, China (PI: L Mu) [40] was conducted in 2000 and included 
206 cases (168 men, 68 women, range 30-82) and 415 controls (287 men, 128 women, 
range 21-84) randomly selected in the general population. Cases and controls were 
frequency matched by age and sex. 
 
The study 12 from Shangai and Qingdao, China (PIs: Yu and ZF Zhang) [41] was 
conducted between 1991 and 1993 on 951 incident primary stomach cancer cases (621 
men, 330 women, mean age 62.5) and 951 controls (621 men, 330 women, mean age 
62.1). Controls were selected from the general population in the same street or 
community of the cases and matched to cases on age and sex. 
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The study 13from Yangzhong, in Jiangsu province in the southeast of China (PI: ZF 
Zhang) [42] was conducted from January 1995 to June 1995. It included 133 newly 
diagnosed cases (93 men, 40 women) and 433 controls (214 men, 219 women) 
selected from a name list of residents in Yangzhong. 
 
The three studies 10, 11 and 19 were conducted in Ardabil, Iran (PI: R Malekzadeh).  
The first one [43] was conducted in 1999 for cases and from 2003 to 2005 for controls. 
It included 217 cases (151 men, 66 women, mean age 65.4) recruited through the 
Ardabil cancer registry, and 394 controls (265 men, 129 women, mean age 64.3) 
randomly selected form the annual household survey of the health department.  
The second one [44] was conducted from August 2005 to August 2007 on 286 cases 
(210 men, 76 women, mean age 66.3) and 304 controls (217 men, 87 women, mean 
age 62.9). Controls were not individually matched to cases and were selected to be 
representative of the Ardabil population aged other 40 years living in rural and urban 
areas. 
The third one [45] included 119 cases (86 men, 33 women, mean age 65.0) and 119 
controls, selected from dyspeptic patients and matched to cases on sex, age and centre. 
 
The study 15 from Aichi, Japan (PI: K Matsuo) (unpublished data) was conducted 
between 2001 and 2005. Cases were selected from the HERPACC-II (Hospital-based 
Epidemiologic Program at Aichi Cancer Canter-II) study which enrolled all first 
outpatients visit aged 20-79, regardless of cancer status. There were 1250 cases (882 
men, 368 women). The 3911 controls were also recruited from the participants of 
HERPACC, and were subjects diagnosed as not having cancer within  1-year from 
random sampling. Cases and controls were individually matched on age and sex. 
 
The study 24 from Japan (PI: H. Ito and K. Matsuo) [46] included 2552 cases and  
5138 hospital controls from the HERPACC-I (1988-2001). Controls were randomly 
selected and individually age-, sex- and enrolment year-matched to cases with a 1: 2~3 
case-control ratio. 
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The study 25, 26 and 27 (PI: L. Lopez-Carillo and R.U. Hernandez-Ramirez) [47]  
The first study [48] was conducted in Mexico city between 1989 and 1990 on 220 
histologically confirmed newly diagnosed cases (122 men and 98 women) and 752 
controls (296 men and 456 women). Controls were frequency matched by age +/- 5 
years and recruited from residents of the Mexico city metropolitan area 
The second study [47] was conducted in Mexico city, Merida and Puebla in Mexico 
between 1994 and 1996 on 324 cases (133 men and  101 women) Histologically confirmed 
incident adenocarcinomas of the stomach and 468 controls (266 men and 202 women) 
matched to case by age (±5 years), sex and city of residence. Controls were recruited in the 
same hospital as cases. 
The third study  [49] was conducted in Mexico city between 2004 and 2005 on 248 
cases (134 men, 114 women) and 478 controls (258 men and 220 women) recruited 
from the general population. 
 
Two studies 28 and 29, from Brazil were conducted between 1991-1994 (PIs: S. 
Tsugane and G.S. Hamada), one was conducted on Japanese Bresilian [50, including 
96 cases and 192 age-, sex-, and race-matched controls, and one was conducted on 
Non-Japanese Brazilian {Nishimoto, 2002 #541] including 236 cases and 236 age-, 
sex-, and race-matched controls. 
 
The study 30, from Japan [51] was conducted from 1998 to 2002 (PI: S. Tsugane) in 4 
hospitals in Nagano and included 153 cases and 301 age-, and sex-matched controls 
(participants of health check-up). 
 
The study 31, from Latvia began the recruitment in 2007 and is still ongoing (PI: M. 
Lja and E. Gasenko) (unpublished data) and project to include 400 cases and 1100 
controls. 
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Table 2. Characteristics of the 31 studies included in the StoP project1 
City/Region, Country Investigator  (recruitment period) 
N  
cases 
N 
controls 
Dataset 
avai-
lable 
Dataset 
harmo- 
nized 
America - 6 studies 
 
2424 7542   
Sao Paulo, Brazil 1 S. Tsugane (1991-1994) 93 186 - - 
Sao Paulo, Brazil 2 S. Tsugane (1991-1994) 226 226 - - 
8 provinces, Canada  K. Johnson, J. Hu (1994-1997) 1182 5039 X X 
Mexico 1, Mexico L. Lopez-Carillo (2004-2005) 248 478 X - 
Mexico 2, Mexico L. Lopez-Carillo (1989-1990) 220 752 X - 
Mexico 3, Mexico L. Lopez-Carillo (1994-1996) 234 468 X - 
New York, MSKCC, USA 1 ZF. Zhang (1992-1994) 134 132 X X 
New York, USA 2 J. Muscat (1980-1990) 87 261 X X 
 
   
  
Europe - 13 studies 
 
5102 11451   
Athens, Greece D. Trichopoulos (1981-1984) 110 100 X X 
Greater Milan, Italy 1 C. La Vecchia (1985-1997) 769 2081 X X 
Greater Milan, Italy 2 E. Negri (1997-2007) 230 547 X X 
Roma, Italy 3 S. Boccia (2006 ongoing) 164 444 X X 
4 areas, Italy 4 D. Palli (1985-1987) 1016 1159 X X 
Porto, Portugal N. Lunet (1999-2006) 568 1585 X X 
Moscow, Russia D. Zaridze (1996-1997) 448 610 X X 
10 provinces, Spain 1 N. Aragones (2008-2012) 400 1800 X X 
South East, Spain 2 J. Vioque (1995-1999) 399 455 X X 
5 counties, Sweden 3 W. Ye (1989-1995) 514 1164 X X 
2 counties (men), Sweden 1 N. Orsini (1997-1998) 93 372 X X 
2 counties (women), Sweden 2 N. Orsini (1997-1998) 176 704 X X 
Latvia M. Leja (2007-ongoing) 215 430 - - 
 
   
  
Asia - 10 studies 
 
6133 12499   
Harbin, China 1 J. Hu (1987-1989) 266 533 X X 
Taixing, Jiangsu, China 2  L. Mu (2000) 206 415 X X 
Shangai, Qingdao, China 3 Y. GuoPei (1991-1993) 951 951 X X 
Yangzhong, China 4 ZF. Zhang (1995) 133 433 X X 
Ardabil, Iran 1 R. Malekzadeh (1999) 217 394 X X 
Ardabil, Iran 2 R. Malekzadeh (2005-2007) 286 304 X X 
Ardabil, Iran 3 R. Malekzadeh 119 119 X X 
Aichi, Japan 1 K. Matsuo (2001-2005) 1250 3911 X X 
Nagoya, Japan 2 H. Ito (1988-2001) 2552 5138 X - 
Nagano, Japan 3 S. Tsugane (1998-2002) 153 301 - - 
 
   
  
TOTAL - 31 studies 
 
13659 31492   
1List at October 2015. 
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2. First main task of the project: harmonization of datasets 
 
The first task consists on merging the different datasets, each one with its specific 
variables as well as with different variable names, format and codes, in order to create 
a single uniform dataset for pooled data analyses. During my first year, I participated 
on it. For that, we collected the variables available for each study and we divided them 
in several main topics as listed in Table 2. For each study, we created a codebook 
reporting which variables are present in each study, their names and their codes. 
Afterwards, we standardized the formats of variables in order to make them uniform 
between datasets and to make them available for pooled data analyses.  
 
We began the work on harmonization on 9 groups of variables (cards). These variables 
were selected among those of first interest for analyses and those required in most 
analyses particularly for adjustment. The harmonisation of datasets is still ongoing. 
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IV. APPLICATION ON THE RELATION BETWEEN CIGARETTE 
SMOKING AND GASTRIC CANCER RISK 
 
1. Studies included in the analysis 
 
We analyzed data from 21 case-control studies of the StoP project, on 10040 cases 
(6624 men, 3414 women) and 25602 controls (15,305 men, 10,297 women) from 
China (3 studies), Iran (2 studies) Japan, Canada, USA (2 studies), Italy (4 studies), 
Greece, Russia, Portugal, Spain (2 studies), and Sweden (3 studies).  
Table 3 shows the distribution of cases and controls by study, sex, age and other 
potential and confounding factors. The proportion of men was slightly higher in cases 
(66.0%) than in controls (59.8%). Cases were somewhat older and have a social class 
lower than controls. They reported more frequently a history of stomach cancer in first 
degree relatives, consumed less vegetables and fruit and declared to drink more 
alcohol than controls. 
Table 3. Distribution of 10 040 cases of pancreatic cancer and 25602 controls according to 
study center, sex, age, and other selected covariates. Stomach cancer pooling (StoP) 
consortium. 
 
Cases Controls 
N % N % 
Total 10040  25602  
Study center     
Asia 2946 29.3 5684 22.2 
02. China 1 (Hu) 266 2.6 533 2.1 
08. China 2 (Mu) 206 2.1 415 1.6 
12. China 3 (Zhang-Yu) 711 7.1 711 2.8 
10. Iran 1 (Malekzadeh) 217 2.2 394 1.5 
11. Iran 2 (Malekzadeh) 286 2.8 304 1.2 
15. Japan (Matsuo) 1260 12.5 3327 13.0 
     
North America 2014 20.6 7253 28.3 
07. Canada (Johnson) 1182 11.8 5039 19.7 
14. USA (Zhang) 132 1.3 132 0.5 
16. USA (Muscat) 700 7.0 2082 8.1 
     
Europe 5080 50.6 12665 49.5 
01. Italy 1 (La Vecchia) 769 7.7 2081 8.1 
03. Italy 2 (Negri) 230 2.3 547 2.1 
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04. Italy 3 (Boccia) 161 1.6 444 1.7 
05. Italy 4 (Palli) 1016 10.1 1159 4.5 
06. Greece (Trichopoulos) 110 1.1 100 0.4 
09. Russia (Zaridze) 450 4.5 611 2.4 
17. Portugal (Lunet) 692 6.9 1667 6.5 
21. Spain 1 (Aragones-Martin) 441 4.4 3441 13.4 
23. Spain 2 (Vioque-Navarrete-Munoz) 401 4.0 455 1.8 
18. Sweden 1 (Wolk-Orsini) 88 0.9 352 1.4 
20. Sweden 2 (Wolk-Orsini) 161 1.6 644 2.5 
22. Sweden 3 (Ye) 561 5.6 1164 4.5 
     
Sex     
Male 6624 66.0 15305 59.8 
Female 3414 34.0 10297 40.2 
     
Age     
<50 1305 13.0 5208 20.3 
50-54 965 9.6 2631 10.3 
55-59 1302 13.0 3069 12.0 
60-64 1562 15.6 4018 15.7 
65-69 1811 18.0 4189 16.4 
70-75 1822 18.1 3822 14.9 
≥75 1273 12.7 2665 10.4 
     
Social class     
Low 5305 52.8 10354 40.4 
Intermediate 2681 26.7 7747 30.3 
High 1237 12.3 5385 21.0 
Missing 817 8.1 2116 8.3 
     
History of stomach cancer in first degree 
relatives1     
No 5014 49.9 12678 49.5 
Yes 876 8.7 1271 5.0 
Missing 4150 41.4 11653 45.6 
     
Vegetables and fruit intake2     
Low 3027 30.1 6807 26.6 
Intermediate 3102 30.9 7655 29.9 
High 2998 29.9 8225 32.1 
Missing 913 9.1 2915 11.4 
     
Alcohol drinking (gr of alcohol/day)3     
Never 2440 24.3 7086 27.7 
Low (< =12) 2080 20.7 7257 28.3 
Intermediate (>12 and <=47) 2406 24.0 5379 21.0 
High (>47) 1134 11.3 2262 8.8 
Missing 1980 19.7 3618 14.1 
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1No information available for studies China 1 (Hu), Canada (Johnson), China 3 
(Zhang-Yu), USA 2 (Muscat), Sweden 1 (Wolk-Orsini) and Sweden 2 (Wolk-Orsini) 
2No information available for the study USA (Muscat) 
3Alcohol drinking was not available in category of consumption for the study Iran 2 
(Malekzadeh), China 3 (Zhang-Yu), Sweden 3 (Ye) 
 
2. Exposure variable: Cigarette smoking 
 
All studies in this pooled analysis provided information about cigarette smoking 
status (never, former, and current smoker), number of cigarettes smoked per day, 
duration of smoking, and time since stopping. Though questions about cigarette 
smoking were similar across studies, we conducted a careful and detailed examination 
of the comparability of smoking-related questions to harmonize the data from the 
multiple studies included in this pooled analysis. 
For the present analyses, ever cigarette smokers were defined as participants who had 
smoked at least 100 cigarettes in their lifetime or more than one cigarette per day for at 
least 1 year. 
For some variable related to the duration of smoking and former smoker status, when 
the type of smoking could not be deduce (cigarette, pipe or cigars) the data was not 
considered. However, when the study did not provide information on the type of 
smoking for the entire smoking variables we considered smoking status (ever, never) 
as valid for cigarette smoking. 
 
3. Statistical methods 
 
To estimate the association between cigarette smoking and pancreatic cancer risk, 
we used a two-stage modeling approach [52]. In the first stage, for categorical 
variables we assessed the association between cigarette smoking and gastric cancer for 
each study by estimating the odds ratios (ORs) and the corresponding 95% CIs using 
multivariable unconditional logistic regression models. These models included, when 
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available terms for age (<40, 40-45, 45-50 50–54, 55–59, 60–64, 65–69, 70–74, ≥75 
years), sex, education (study-specific low, intermediate, high), race/ethnicity (White, 
Hispanic/Latino, Black/African american, other), alcohol drinking consumption 
(Never, low ≤12 gr/day, intermediate >12-≤47 gr/day, high >47 gr/day) and study 
center for multicentric studies. 
For continuous variable, we assessed the estimation of the odds ratios (ORs) and 
the corresponding 95% CIs using one-order and two-order fractional polynomial 
models. The best fitting model was define as the one minimizing the deviance.  
Using a macro program we developed on SAS software (SAS Institute Inc, Cary, 
NC) (See Supplements), 8 first-order and 36 second-order fractional polynomial 
models were generated  with the power vector P={-2;-1;-0.5;0;0.5;1;2;3}. For each 
models, the deviance was generated. In a first step we compared all first-order 
polynomials and then all second-order to the linear model (model with a first-order 
fractional polynomial with the power p=1).  
For the number of cigarettes per day the best model was defined with powers p1=-2 
and p2=2, FP2= β0 + β1 (Num_Cigarettes)-2 + β2 (Num_Cigarettes)2. And the same 
powers was found for the duration of smoking FP2= β0 + β1 (Years of smoking)-2 + β2 
(Years of smoking)2 
In the second stage, the pooled estimation was calculated using a random effects 
model and the moment estimation method. 
For categorical variables, heterogeneity between studies was evaluated using the 
Q test statistic.  
For categorical variables, we tested the linear trends across levels of cigarette 
smoking; we first estimated trends in each study and used the Wald test to estimate the 
P value of the summary variable from the random-effects models (ref Smith-Warner 
2006). To investigate whether the effect of cigarette smoking was homogenous across 
strata of selected covariates, we conducted analyses stratified by age, sex and 
geographic area. Heterogeneity across strata was assessed using the Q test statistic. 
Pooled estimations were generated using R software and the function metagen 
from the library “meta” (See supplements). 
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Corresponding graphics and forest plot were created using R software and the library 
“gplot”. 
We also conducted a sensitivity analysis to evaluate the influence of Helicobacter 
pylori (HP) infection information by excluding all studies without the information in a 
first time and in a second time considering only HP positive controls. 
 
4. Results 
 
4.1. Category of smoker 
 
The pooled ORs for gastric cancer according to cigarette smoking habits are 
given in Table 4. Concerning studies where the former status was available, ORs was 
1.19 (95% CI 1.08-1.30) for ever cigarette smokers, 1.14 (95% CI 1.01-1.29) for 
former cigarette smokers and 1.22 (95% CI 1.06-1.40) for current smokers, compared 
with never smokers. Among current smokers, the risk increased with categories of the 
number of cigarettes smoked per day. Compared to never smokers, ORs were 1.05 
(95% CI 0.88-1.26) for 0 to 10 cigarettes per day, 1.27 (95% CI 1.11-1.45) for 10 to 
20 cigarettes per day and 1.29 (95% CI 1.06-1.57) for more than 20 cigarettes per day, 
with a significant trend (p=0.005). The risk increased also significantly with increasing 
duration of smoking (p value for trend p<0.0001) and with ORs in category equal to 
1.04 (95%CI 0.94-1.16) for less than 30 years of smoking, 1.32 (95% CI 1.16-1.49) 
for a duration between 30 to 40 years of smoking and 1.33 (95% CI 1.14-1.54) for 
more than 30 years of cigarette smoking. A significant decreasing trend in risk was 
found with an increase time since stopping cigarette smoking (p=0.02) taking as 
reference current smokers (Table 4).  
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Table 4. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) for gastric cancer 
according to cigarette and tobacco smoking habits. Stomach cancer pooling (StoP) 
consortium. 
 
Cases Controls OR1 (CI 95%) N % N % 
Total 10039  25596   
Cigarette smoking status      
Never smoker 4122 41.1 11396 44.5 1 
Ever cigarette smoker 5510 54.8 13516 52.8 1.19 (1.08-1.30) 
Former cigarette smoker 2775 27.6 7421 29.0 1.14 (1.01-1.29) 
Current cigarette smoker 2735 27.2 6095 23.8 1.22 (1.06-1.40) 
Other than cigarette smoker 121 1.2 343 1.3 1.09 (0.79-1.50) 
Missing 288 2.9 350 1.4  
 
     
Intensity (cigarettes per day)3      
0 to ≤10 674 6.7 1820 7.1 1.05 (0.88-1.26) 
>10 to ≤20 1285 12.8 2696 10.5 1.27 (1.11-1.45) 
> 20 748 7.5 1497 5.8 1.29 (1.06-1.57) 
missing 316 3.2 432 1.7  
P value for trend     0.005 
      
Cigarette smoking duration 
(years)      
0 to ≤30 2213 22.0 6921 27.0 1.04 (0.94-1.16) 
>30 to ≤40 1420 14.1 3031 11.8 1.32 (1.16-1.49) 
> 40 1661 16.5 3009 11.8 1.33 (1.14-1.54) 
missing 504 5.0 905 3.5  
P value for trend 
    
<0.0001 
 
     
Total3 7657  18222   
Time since stopping  cigarette 
smoking (years)      
Never smoker 3204 41.8 8212 45.1 1 
0 to <10 674 8.8 1543 8.5 1.15 (0.95-1.39) 
10 to <20 513 6.7 1391 7.6 1.07 (0.94-1.23) 
≥ 20 616 8.0 1718 9.4 1.03 (0.87-1.21) 
Other than cigarette smoker 121 1.6 343 1.9  
Missing 280 3.7 482 2.6  
P value for trend     0.1628 
      
Time since stopping cigarette 
smoking (years)      
Current cigarette smoker 2249 29.4 4533 24.9 1 
0 to <10 674 8.8 1543 8.5 0.92 (0.73-1.16) 
10 to <20 513 6.7 1391 7.6 0.82 (0.72-0.94) 
≥ 20 616 8.0 1718 9.4 0.84 (0.66-1.07) 
Other than cigarette smoker 121 1.6 343 1.9  
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Missing 280 3.7 482 2.6  
P value for trend     0.018 
1Pooled ORs were computed using random-effects models, study-specific ORs were 
adjusted, when available, for sex, age, race/ethnicity, social class, alcohol drinking, fruit 
and vegetable consumption and study center for multicentric studies. 2Cigarette 
smoking status was not available studies China 4 (Zhang) and Iran 3 (Malekzadeh).  
3Current smokers only 4Time since stopping cigarette smoking was not available for 
studies Greece (Trichopoulos), Canada (Johnson), China 1 (Mu), Iran 1 (Malekzadeh), 
Iran 2 (Malekzadeh), USA 1 (Zhang), Sweden 1 (Wolk-Orsini), and Sweden 2 (Wolk-
Orsini) 
 
A forest plot of the study-specific and the pooled ORs for gastric cancer risk 
for ever smokers compared to never smokers are given in Figure 5.  
 
 
Figure 5: Pooled OR and corresponding 95% confidence interval for gastric cancer risk for 
ever smokers compared to never smokers, Stomach cancer pooling (StoP) consortium.  
 
4.2. Number of cigarettes per day 
 
A forest plot of the study-specific and the pooled ORs for gastric cancer risk 
for numbers of cigarettes smoked per day among current smoker compared to never 
- 43 - 
 
smokers are given in Figure 6. The heterogeneity across study was significant for each 
category of consumption. 
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Figure 6: Pooled OR and corresponding 95% confidence interval for gastric cancer risk for former smokers (a), smokers of less than 10 cigarettes (b), 
smokers of 10 to 20 cigarettes (c) and smokers of more than 20 cigarettes (d)  compared to never smokers, Stomach cancer pooling (StoP) consortium. 
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Figure 7 represented the relation between gastric cancer risk and the number of 
cigarette smoking. The relation is fitted by a fractional polynomial. For the number of 
cigarettes per day the best fitting model was defined with powers p1=-2 and p2=2, 
FP2= β0 + β1 X-2 + β2 X2. This curve represented the increasing risk of gastric cancer 
with increasing risk of smoking cigarettes per day. It showed that the risk increased 
slightly for up to 2 packs of cigarettes and the increase appeared to be stronger after. 
The fractional polynomial is significantly different from linear model (p<0.0001) 
 
 
 
Figure 7: Relation between number of smoking cigarettes per day and risk of gastric cancer 
fitted by a fractional polynomial FP2= β0 + β1 X-2 + β2 X2 and a linear model, Stomach cancer 
pooling (StoP) consortium.  
 
 
Table 5 showed a contrast between results across categorical model, linear model and 
fractional polynomials. 
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Table 5. Contrast of pooled odds ratios (ORs) and 95% confidence intervals (CIs) for gastric 
cancer estimated according to the number of smoking cigarettes per day and in continuous 
through a linear model and second-order fractional polynomials. Stomach cancer pooling 
(StoP) consortium. 
Cigarettes per day 
Categorization Fractional polynomials 
Range OR cat Range Ref. point 
OR linear OR FP2 
Never 1.00 Never 0 1.00 1.00 
1 – 10 1.07 (0.90-1.27) 1 – 10 5 1.03 (1.02-1.04) 1.00 (0.99-1.00) 
11 to 20 1.28 (1.10-1.48) 11 – 30 15 1.11 (1.07-1.14) 1.01 (0.99-1.02) 
21 + 1.29 (1.06-1.57) 31 – 50 25 1.19 (1.11-1.25) 1.01 (0.98-1.05) 
  51 – 60 35 1.27 (1.17-1.37) 1.03 (0.96-1.10) 
  61 – 70 45 1.36 (1.22-1.50) 1.05 (0.93-1.18) 
  71 – 80 55 1.46 (1.28-1.65) 1.07 (0.89-1.28) 
   65 1.56 (1.33-1.81) 1.10 (0.85-1.42) 
   75 1.67 (1.40-1.98) 1.14 (0.81-1.59) 
 
The association between the number of cigarettes smoked in category and 
gastric cancer risk was further assessed in strata of sex, age and geographic area. We 
noticed a stronger effect of duration for men in for smokers for less than 10 years, for 
young smokers for more than 30 years (Figure 8). Similar risks were found for cardia 
and non-cardia gastric cancer cases. Considering only studies with the information on 
HP infection, effects of cigarette smoking did not materially when taking into account 
controls with a positive HP infection test in our analyses. We further considerate 
separately controls recruited from hospital and those recruited in the general 
population. Risks appeared to be slightly higher in the analyses with hospital controls. 
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Figure 8: Pooled odds ratios (ORs)1 and 95% confidence intervals (CIs) for gastric cancer 
according to cigarette smoking status in strata of sex, age, geographic area, cancer site,  
Helicobacter Pylori infection, controls recruitment. Stomach cancer pooling (StoP) 
consortium. 
1The study Italy 3 (Boccia) and Spain 2 (Vioque) were not considered because controls were all HP 
negative 
Considered studies :  China 2 (Mu), Iran 1, Iran 2 (Malekzadeh), Japan (Matsuo), Portugal (Lunet), 
Russia (Zaridze), Spain 1 (Aragones-Martin), Sweden 3 (Ye) 
2Considered studies: Italy 1 (La Vecchia), Italy 2 (Negri), Italy 3 (Boccia), Italy 4 (Palli), Canada 
(Johnson), Russia (Zaridze), Iran 1, Iran 2 (Malekzadeh), USA 1 (Zhang), Japan (Matsuo), USA 2 
(Muscat), Portugal (lunet), Sweden 1, Sweden 2 (Wolk-Orsini), Spain 1 (Aragones-Martin), Sweden 3 
(Ye), Spain 2 (Vioque) 
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The study Greece (Trichopoulos) was not considered because all its cases had  a non-cardia neoplasm 
For the category 10-20 cig/day, the study 14 USA 1 (Zhang) was not considered because of lack of 
cases 
For the category >20 cig/day,  studies 01.Italy 1 (La Vecchia) and  18.Sweden 1 were not considered 
because of lack of cases. 
3Pooled ORs were computed considering only controls with a positive test of helicobacter pylori 
infection 
 4Considered studies: Italy 1 (La Vecchia), China 1 (Hu), Italy 2 (Negri), Italy 3 (Boccia), Greece 
(Trichopoulos), USA 1 (Zhang), Japan (Matsuo), USA 2 (Muscat), Spain 2 (Vioque) 
5Considered studies:  Italy 4 (Palli), Canada (Johnson), China 2 (Mu), Iran 1, Iran 2 (Malekzadeh), China 3 
(Zhang-Yu), Portugal (lunet), Sweden 1, Sweden 2 (Wolk-Orsini), Spain 1 (Aragones-Martin), Sweden 3 
(Ye) 
The study Russia (Zaridze) was not considered in this analysis because it considers both hospital and general 
population controls 
 
 
4.3. Duration of smoking in years. 
 
A forest plot of the study-specific and the pooled ORs for gastric cancer risk 
for the duration of smoking cigarettes compared to never smokers are given in Figure 
9. The heterogeneity across study was significant only for the category of smokers for 
more than 30 years. 
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Figure 9: Pooled OR and corresponding 95% confidence interval for gastric cancer risk for subjects smoking less than 10 years (a), between 10 and 30 years 
(b) and more than 30 years (c) compared to never smokers, Stomach cancer pooling (StoP) consortium. 
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Figure 10 represented the increasing risk of gastric cancer with increasing duration of 
smoking fitted by a linear model and by a fractional polynomial. The best fitting 
model was defined with powers p1=-2 and p2=2, FP2= β0 + β1 X-2 + β2 X2. This graph 
provided the evidence of strong non linear dose relationship between risk of gastric 
cancer and increasing duration of cigarette smoking. The fractional polynomial is 
significantly different from linear model (p<0.0001) AIC=-645.5. The fractional 
polynomial suggested a stronger increase of risk after 20 years of smoking. 
 
Figure 10: Relation between duration of smoking and risk of gastric cancer fitted by a 
fractional polynomial FP2= β0 + β1 X-2 + β2 X2, and a linear model, Stomach cancer 
pooling (StoP) consortium.  
 
Table 6 showed a contrast between results across categorical model, linear model and 
fractional polynomials. 
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Table 6. Contrast of pooled odds ratios (ORs) and 95% confidence intervals (CIs) for gastric 
cancer estimated according to the number of smoking cigarettes per day and in continuous 
through a linear model and second-order fractional polynomials. Stomach cancer pooling 
(StoP) consortium. 
Cigarette smoking duration (years) 
Categorisation Fractional polynomials 
Range OR cat Range Ref. point OR linear OR FP2 
Never  Never 0 1.00 1.00 
1 – 10 0.77 (0.67-0.89) 1 – 10 5 1.04 (1.03-1.04) 1.00 (1.00-1.00) 
11 to 30 1.14 (1.04-1.26) 11 – 30 20 1.17 (1.13-1.20) 1.06 (1.02-1.08) 
31 + 1.32 (1.17-1.49) 31 – 50 40 1.37 (1.28-1.45) 1.25 (1.10- 1.38) 
  51 – 60 55 1.54 (1.40-1.67) 1.52 (1.21-1.85) 
  61 – 70 65 1.67 (1.49-1.84) 1.79 (1.31-1.85) 
  71 – 80 75 1.81 (1.59-2.02) 2.17 (1.43-3.17) 
 
The association between smoking duration and gastric cancer risk was further assessed 
in strata of sex, age and geographic area. We noticed a stronger effect of duration for 
men in for smokers for less than 10 years, for young smokers for more than 30 years 
(Table 7).  
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Table 7. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) for gastric cancer according to cigarette smoking duration in strata of selected 
covariates among 10040 cases and 25602 controls. Stomach cancer pooling (StoP) consortium.  
 Never 0-≤10 years >10-≤30 years >30 years 
 Ca : Co Ca : Co OR (95% CI) Ca : Co OR (95% CI) Ca : Co OR (95% CI) 
Overall 4120:11390 347:1576 0.77 (0.67-0.89) 1823:5267 1.14 (1.04-1.26) 3115:6095 1.32 (1.17-1.49) 
        
Sex        
Men 1597:4484 270:978 0.86 (0.73-1.02) 1482: 3824 1.21 (1.06-1.38) 2751:4942 1.39 (1.20-1.60) 
Women 2523:6906 77:598 0.58 (0.43-0.77) 341:1443 1.11 (0.94-1.30) 364:1153 1.17 (0.98-1.40) 
P for interaction   0.0183  0.3977  0.1482 
        
Age        
≤55 961:3624 124:826 0.74 (0.58-0.95) 842:2678 1.20 (0.98-1.48) 427:982 1.50 (1.19-1.90) 
<55 - ≤65 1076:3152 102:358 0.75 (0.59-0.96) 486:1326 1.20 (1.02-1.41) 1148:2224 1.46 (1.24-1.71) 
>65 2083:4610 121:392 0.99 (0.74-1.33) 4951263 1.03 (0.88-1.19) 15402889 1.15 (1.02-1.30) 
P for interaction   0.2587  0.2884  0.0295 
        
Geographic 
area 
       
America 551:2644 107:688 0.83 (0.65-1.06) 504:1835 1.25 (1.07-1.47) 630:1754 1.40 (1.04-1.91) 
Asia 1358:2884 72:170 1.00 (0.71-1.42) 448:1003 1.20 (0.82-1.75) 941:1379 1.51 (1.22-1.86) 
Europe 2211:5862 168:718 0.67 (0.55-0.82) 871:2429 1.07 (0.96-1.20) 1544:2962 1.21 (1.05-1.39) 
P for interaction   0.1177  0.2823  0.2075 
        
1Pooled ORs were computed using random-effects models, study-specific ORs were adjusted, when available, for sex, age, race/ethmicity, social 
class, alcohol drinking, fruit and vegetable consumption and study center for multicentric studies 2Reference category 
Ca, cases, Co, controls 
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5. Discussion  
 
Results from our analysis confirm that there is an association between cigarette 
smoking and gastric cancer risk. A 20% excess risk of gastric cancer was found among 
current smoker. This risk significantly increase with the number of cigarettes per day 
to reach 29% of excess risk for smokers of more than 20 cigarettes and, with duration 
to reach 32% of excess risk for smokers smoking for more than 30 years compared to 
never smokers. The effect of duration seems to be somewhat stronger in younger 
subjects and in men. However, this risk declines with times since stopping and seems 
to reach the level of never cigarette smokers since 10 years after quitting.  
These effects of increasing risk are confirm by different statistical models of 
analysis  including linear model and fractional polynomials, considering the number of 
cigarettes per day and the duration as a continuous variable. 
The categorization of the number of smoking cigarettes needs to be interpreted 
carefully. In almost all cases, cigarette consumption is assessed by self-report. Because 
cigarettes are packaged in packs of 20, smokers often represent their cigarette 
consumption around that number or multiples of number of packs per day and the 
number of cigarette can be biased.  
These results are consistent with previous meta-analyses. The OR estimates for 
current cigarette smokers were slightly lower than that reported in the previous 
investigations which found an increasing risk comprised between 1.5 and 1.6 [8, 9, 
53]. 
 Among strength of the study, the StoP included original and detail data about 
cigarette smoking for about 10,000 cases and 25,000 controls, which provided a 
unique opportunity to investigate and quantify accurately the dose- and duration- risk 
relationships, and among former smokers, the pattern of risk with time since stopping. 
Our study included a large number of subjects, increasing our ability to examine 
relationships between risk factor and gastric cancer risk. 
Another advantage of our study was detailed information on important covariates, 
we adjusted on major risk factor of gastric cancer and conducted stratified analysis by 
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demographic factors including sex, age and geographic area. Having information on 
the main risk factor of gastric cancer, we could lead subanalyses on studies with 
helicobacter pylori infection information and particularly fixing the effect of HP 
infection analyzing only controls with a positive infection to HP (all cases being 
supposed to be infected to HP). 
We were able to take into account heterogeneity across study because of 
appropriate statistical methods and particularly we could confirm our main results 
thanks to alternative statistical methods to analyze continuous variables.  
 
The relationship between cigarette smoking and gastric cancer may be discerned 
from the categorical analysis, but the analysis of the variable in continuous through 
polynomials brought additional information in particular to understand the possible 
threshold and a possible change in slopes. Moreover, in a pooled analysis 
heterogeneity across study can brought differences on the meaning and definition of  
cutpoints choice and interpretation could be biased. 
 
Moreover, fractional polynomials are an approach transparent, informative, 
flexible and more realistic than estimation using categories. 
However if categorization should be done, in particular for continuous confounders 
but to avoid excessive bias caused residual confounding, at least four categories are 
needed [54, 55]. 
The point of this thesis is to adapt fractional polynomials to be used in a two stage 
analysis. This method has been developed previously by Rota et al. to use specifically 
in meta-analyses. We decided to adapt it to pooled case-control studies (and it would 
be the same for individual patient data meta analyses). During my second year of PhD, 
I considered also restricted cubic spline as a method for studying non-linear 
relationship. Analyses on aggregated data gave similar results, but splines are more 
complex in particular in the choice of the number and the value of nodes.  
To our knowledge all studies on individual patient data meta-analysis which 
considered continuous variable through spline, fractional polynomials and other 
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models from the GAM family, based their analisis on a one-stage approach. This 
method consists in fitting a regression model, generally a random effect model, 
adjusting for confounding variables and the effect of the study [56]. However, the 
availability of confounding variable can varies across study, and it is the cas in the 
StoP project, the variable adjustment need to be restricted. For this reason the use of 
the two-stage analysis in the StoP project is inevitable and also preferable in order to 
include all the study members of the consortium. 
However, when the majority of missing data are the results of non-availability of 
certain variables in some studies, the use of both multiple imputation and the missing-
data indicator could be helpful in order to compare results between a one-stage and 
two-stage analysis [57]. Nevertheless, It would be likely to introduce a bias in 
comparison with the complete case-method [58] and a two-stage approach would be 
prefered[57]. 
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V. CONCLUSION AND PERSPECTIVES 
 
During my PhD, I took part of the international consortium of case-control studies on 
gastric cancer, the “Stomach cancer Pooling (StoP) Project” and specifically in the study 
of adequate methods to analyze continuous variables in a  pooled case-control studies. 
During this 3 year, I went 6 months at the Mount Sinai hospital in New York to work with 
Prof. Paolo Boffetta, I had the chance to be involved in two projects on alcohol and cancer 
which both allowed me to write two scientific publications. 
Since a large harmonized data are available in the StoP project (23 studies), I could apply 
the statistical methods I studied and learn on tobacco smoking and gastric cancer risk. I 
analyzed in particular continuous risk variables (number of smoked cigarettes per day and 
the smoking duration) through the classical approach, categorizing the continuous 
variable, the linear model and fractional polynomials (first and second order), all methods 
in a two-stage approach. The three methods led to similar conclusions regarding the 
association between smoking and gastric cancer risk but polynomials gave additional 
information in particular to understand the possible threshold and changes in slopes. 
Further considerations could be lead in the future, in particular regarding if other flexible 
methods, i.e. spline or methods from the GAM family, bring similar results. Moreover, in 
order to take advantage of the large number of cases and controls, continuous variables it 
could be interesting to compare our result to a one stage approach overcoming to missing 
variables using multiple imputation or missing-data indicator methods [59]. 
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SUPPLEMENTS 
 
1. SAS Macro for fractional polynomials 
/******************************************************************** 
     MACRO MFP 
 
Macro that build the dataset in order to fit first order fractional 
polynomials 
 
Input parameters->  
powers: vector containing the list of powers we want to try in our 
fractional polynomials vector  
data:   dataset containing our dataset 
var:    dependant continuous variable 
 
********************************************************************/ 
%macro MFP1(powers,data,var,num_studies); 
 
*** count the number of different powers to test ; 
proc iml; 
 a=ncol({&powers}); /* counter of the number of power in the vector 
*/ 
 create tt from a[colname="n_powers"];  /* create a dataset which 
contained a */ 
 append from a; 
data s; 
 set tt; 
 call symput('cont',n_powers); 
run; 
quit; 
*** create a dataset with the value of p1 in funzione of its rank in 
the vector; 
%do j=1 %to &cont;       /* counter of the power p1 */   
  %let a=%qscan(&powers,&j,%str( )); 
     data new; 
       set &data; 
    %if &a ne 0 %then %do;   /* p1 different from 0 */ 
        p1=&var**(&a); %end; 
    %else %do;     /* p1=0*/ 
        p1=log(&var); %end; 
  run;     
       %logistic1(new,&a,&j,&risposta,&num_studies);  
%end; 
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/******************************************************************** 
MACRO LOGISTIC 
 
OGGETTO: fit the logistic regression on the variable for each power 
Input parameters->  
dataset: dataset containing the transformed variable with the power  
p1:      the transformed explicative variable  
index:   index which for the 8 polynomials 
y:    represent the explained variable 
num_studies: the number refered to the last study considered 
********************************************************************/ 
 
 
options symbolgen mprint; 
%macro logistic1(dataset,p1,index,y,num_studies); 
 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," "))); 
 
 %let stud=%scan(&studies,&nstudy," "); 
 
*** create a dataset for each study; 
 data st&stud; 
 set &dataset; 
 if va2=&stud. and va2 in (&studies); 
 run; 
 
*** compute the logistic model for each study and for each power 
taking out the beta estimate and the coresponding variance; 
   title "Study &stud."; 
   proc logistic data=st&stud; 
   class &&study&stud.  / ref=FIRST param=ref; 
   model &y=p1  &&study&stud. / link=logit covb; 
   *where va2=&stud.; 
   ods output ParameterEstimates=StimaBeta&stud 
CovB=StimaCov&stud /*FitStatistics=Fit_for_label&i*/; 
   run; 
   quit; 
 
*** create a dataset with betas for each power; 
  data StimaBeta&stud; 
  set StimaBeta&stud; 
  powers_1=&p1; 
  va2=&stud; 
  if Variable eq "p1"; 
  drop ClassVal0 DF WaldChiSq ProbChiSq; 
  run; 
  quit; 
 
*** create a dataset with the variances for each power; 
  data StimaCov&stud; 
  set StimaCov&stud; 
  if Parameter eq "p1" ; 
  va2=&stud; 
  rename p1=var_p1; 
  keep p1 va2; 
  run; 
 %let nstudy=%eval(&nstudy+1); 
%end; 
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*** Create a dataset merging beta estimates of each study together 
with each power; 
data beta; 
set 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," "))); 
 %let stud=%scan(&studies,&nstudy," "); 
 Stimabeta&stud 
 %let nstudy=%eval(&nstudy+1); 
 %end; 
; 
b=1; 
run; 
 
*** Create a dataset merging variance estimates of each study 
together with each power; 
data covb; 
set 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," "))); 
 %let stud=%scan(&studies,&nstudy," "); 
 Stimacov&stud 
 %let nstudy=%eval(&nstudy+1); 
 %end; 
run; 
 
 
*** Create the dataset "longformat" with the variances in the format 
needed for the proc mixed; 
proc transpose data=covb out=w(drop=_name_); 
 var var_p1; 
run; 
 
proc iml; 
use w; 
read all into d; 
d={0}||d; 
nc=ncol(d); 
num=1:nc; 
colname=cat('CovP',num); 
create longformat from d [colname=colname]; 
append from d; 
 
quit; 
 
*** Estimate the pooled beta for each power.  
M1-M8 datasets contain the pooled beta for each power.  
F1-F8 datasets ccontain -2logV AIC ... for each power; 
title "Pooled"; 
proc mixed data=beta covtest cl; 
 class va2; 
 model estimate=b /noint solution cl covb; 
 random b /subject=va2 g solution type=un; 
 repeated /subject=va2 group=va2 type=un; 
 parms/parmsdata=longformat hold=2 to &num_studies.+1; 
 ods output SolutionF=m&index FitStatistics=f&index; 
run;quit; 
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data m&index; 
set m&index; 
 powers_1=&p1; 
run; 
 
 
* F1-F8 datasets ccontain -2logV for each power; 
data f&index.verosim; 
set f&index; 
if Descr eq "-2 res log verosim"; 
*if Descr eq "-2 Res Log Likelihood"; 
powers_1=&p1; 
run; 
 
* F1-F8 datasets ccontain AIC for each power; 
data f&index.aic; 
set f&index; 
if Descr eq "AIC (minore è meglio)"; 
*if Descr eq "AIC (smaller is better)"; 
powers_1=&p1; 
run; 
 
* create an only one dataset merging F1-F8 with -2logV; 
data fitverosim; 
set 
%do l=1 %to &cont; 
    f&l.verosim 
%end; 
run; 
 
* create an only one dataset merging F1-F8 with AIC; 
data fitaic; 
set 
%do l=1 %to &cont; 
    f&l.aic 
%end; 
run; 
 
* create an only one dataset with beta estimates for each power; 
data coeff1; 
set 
%do l=1 %to &cont; 
    m&l 
%end; 
run; 
%mend; 
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/******************************************************************** 
MACRO MFP2 
 
Macro that build the in order to fit second order fractional 
polynomials 
 
Input parameters->  
powers: vector containing the list of powers we want to try in our 
fractional polynomials vector  
data:   dataset containing our data 
var:    dependant continuous variable 
num_studies: the number refered to the last study considered 
********************************************************************/ 
 
%macro MFP2(powers,data,var,num_studies); 
 
 
proc iml; 
a=ncol({&powers}); /* counter of the number of power in the vector */ 
create tt from a[colname="n_powers"];  /* create a dataset which 
contained a */ 
append from a; 
data s; 
set tt; 
call symput('cont',n_powers); 
run; 
quit; 
 
%do j=1 %to &cont;    /* counter of the power p1 */   
%do k=1 %to &cont;    /* counter of the power p2 */   
 
 %if &j=&k %then %do; /* p1=p2 */    
  %let a=%qscan(&powers,&j,%str( )); 
  data new; 
  set &data; 
  %if &a ne 0 %then %do;   /* p1=p2 different from 0 */ 
   p1=&var**(&a); 
   p2=&var**(&a)*log(&var); 
   %end; 
  %else %do;     /* p1=p2=0*/ 
   p1=log(&var); 
   p2=(log(&var))**2; 
   %end; 
  run; 
 
  %logistic2(new,&a,&a,&k&j,&risposta,&num_studies);  
 
  %end; 
 
 
 %else %do; /* p1 not equal to p2 */ 
  %let a=%qscan(&powers,&j,%str( )); 
  %let b=%qscan(&powers,&k,%str( )); 
  data new; 
  set &data; 
  %if &a ne 0 AND &b ne 0 %then %do; /* p1 and p2 not equal 
to 0 */ 
   p1=&var**(&a); 
   p2=&var**(&b); 
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   %end; 
  %else %if &a eq 0 AND &b ne 0 %then %do; /* p1=0 but p2 
not equal to 0 */ 
   p1=log(&var); 
   p2=&var**(&b); 
   %end; 
  %else %do; 
   p1=&var**(&a); 
   p2=log(&var); 
   %end; 
  run;   
  %logistic2(new,&a,&b,&j&k,&risposta,&num_studies);  
 
  %end;  
%end; 
%end; 
 
%mend; 
 
/******************************************************************** 
MACRO LOGISTIC2 
 
OGGETTO: fit the logistic regression on the variable for each power 
 
Input parameters->  
dataset:  dataset containing the transformed variable with the 
power  
p1:       the transformed explicative variable  
p2:       the transformed explicative variable  
index:    index which for the 36 polynomials 
y:   represent the explained variable 
num_studies: the number refered to the last study considered 
********************************************************************/ 
options symbolgen mprint; 
%macro logistic2(dataset,p1,p2,index,y,num_studies); 
 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," "))); 
 
%let stud=%scan(&studies,&nstudy," "); 
 
*** create a dataset for each study; 
data st&stud; 
set &dataset; 
if va2=&stud. and va2 in (&studies); 
run; 
 
*** compute the logistic model for each study and for each couple of 
powers taking out the beta estimate and the coresponding variance; 
  title "Study &stud."; 
  proc logistic data=st&stud; 
  class &&study&stud.  / ref=FIRST param=ref; 
  model &y=p1 p2  &&study&stud. / link=logit covb; 
  ods output ParameterEstimates=StimaBeta&stud 
CovB=StimaCov&stud ; 
  run; 
  quit; 
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*** create a dataset with betas for each power; 
data StimaBeta&stud; 
set  StimaBeta&stud; 
powers_1=&p1; 
powers_2=&p2; 
va2=&stud; 
if Variable = "p1" or variable="p2" then output; 
drop ClassVal0 DF WaldChiSq ProbChiSq; 
run; 
quit; 
 
*** create a dataset with the variances for each power; 
data StimaCov&stud; 
set  StimaCov&stud; 
if Parameter = "p1" then do; p1bis=p1;end; 
var_p1st&stud=lag1(p1bis); 
if Parameter="p2" then do;cov_p1p2st&stud=p1; var_p2st&stud=p2;end; 
if Parameter="p2" then output; 
keep var_p1st&stud var_p2st&stud cov_p1p2st&stud; 
run; 
%let nstudy=%eval(&nstudy+1); 
%end; 
  
*** Create a dataset merging beta estimates of each study together 
with each power; 
data beta; 
set 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," "))); 
 %let stud=%scan(&studies,&nstudy," "); 
 Stimabeta&stud 
 %let nstudy=%eval(&nstudy+1); 
 %end; 
; 
 
if variable="p1" then b1=1;else b1=0; 
if variable="p2" then b2=1;else b2=0; 
 
run; 
 
*** Create a dataset merging variance estimates of each study 
together with each power; 
data covb; 
merge 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," "))); 
 %let stud=%scan(&studies,&nstudy," "); 
 Stimacov&stud 
 %let nstudy=%eval(&nstudy+1); 
 %end; 
; 
run; 
 
 
*** Create the dataset "longformat" with the variances in the format 
needed for the proc mixed; 
proc iml; 
use covb; 
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read all into d; 
d={0}||{0}||{0}||d; 
nc=ncol(d); 
num=1:nc; 
colname=cat('CovP',num); 
create longformat from d [colname=colname]; 
append from d; 
 
quit; 
 
 
data _null_; 
call symput('num_col',&num_studies*3+3); 
run; 
 
*** Estimate the pooled beta for each power.  
M1-M88 datasets contain the pooled beta for each couple of power.  
F1-F888 datasets ccontain -2logV AIC ... for each couple of power; 
title "Pooled"; 
ods graphics on; 
proc mixed data=beta covtest cl; 
 class va2; 
 model estimate=b1 b2 /noint solution cl covb; 
 random b1 b2 /subject=va2 g solution type=un; 
 repeated /subject=va2 group=va2 type=un; 
 parms/parmsdata=longformat hold=4 to &num_col; 
 ods output SolutionF=m&index FitStatistics=f&index; 
run; 
quit; 
ods graphics off; 
 
data m&index; 
set m&index; 
powers_1=&p1; 
powers_2=&p2; 
run; 
 
data f&index.aic; 
set f&index; 
if Descr eq "AIC (minore è meglio)"; 
powers_1=&p1; 
powers_2=&p2; 
run; 
 
data f&index.verosim; 
set f&index; 
if Descr eq "-2 res log verosim"; 
powers_1=&p1; 
powers_2=&p2; 
run; 
 
data fitaic; 
set 
%do l=1 %to &cont; 
%do m=1 %to &cont; 
     f&l&m.aic 
%end; 
%end; 
; 
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run; 
data fitverosim; 
set 
%do l=1 %to &cont; 
%do m=1 %to &cont; 
     f&l&m.verosim 
%end; 
%end; 
; 
run; 
proc sort data=fitaic;by Value; run; 
proc sort data=fitverosim;by Value; run; 
 
* create an only one dataset with beta estimates for each power; 
data coeff2; 
set 
%do l=1 %to &cont; 
%do m=1 %to &cont; 
      m&l&m 
%end; 
%end; 
; 
run; 
 
%mend; 
 
2. R programs for fractional polynomials 
Example of program to build the graphic 
#second order polynomials 
eta1<- -0.00002 
beta2<- 0.000022 
 
numcig<-seq(0.01,100,1) 
a<-numcig^-2 
b<-numcig^2 
 
matx<-cbind(a,b) 
 
predicted<-exp(beta1*a+beta2*b) 
cov<-matrix(nrow=2,ncol=2) 
 
cov[1,1]<-  2.07E-11 
cov[1,2]<-  -212E-13 
cov[2,1]<-cov[1,2] 
cov[2,2]<-  8.48E-10 
 
lb_predicted<-exp((beta1*a+beta2*b)-1.96*sqrt(diag(matx%*%cov%*%t(matx)))) 
ub_predicted<-exp((beta1*a+beta2*b)+1.96*sqrt(diag(matx%*%cov%*%t(matx)))) 
predicted[1]<-1 
lb_predicted[1]<-1 
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ub_predicted[1]<-1 
predicted 
 
#linear trend 
beta<- 0.007640 
var<- 0.001136 
predicted_lin<-exp(beta*numcig) 
 
lb_predicted_lin<-exp((beta*numcig)-1.96*sqrt(numcig*var*t(numcig))) 
ub_predicted_lin<-exp((beta*numcig)+1.96*sqrt(numcig*var*t(numcig))) 
summary(numcig) 
predicted 
 
# graph FP e linear together 
plot(numcig,predicted,type="l",xlab="Number of smoking cigarettes per 
day",ylab="OR",xlim=c(0,100),ylim=c(0.5,4),log="y",yaxt="n") 
axis(2,at=c(0.5,1,2,4),las=1) 
 
polygon(c(numcig, rev(numcig)), c(ub_predicted, rev(lb_predicted)), 
        col = "gray87", border = NA) 
lines(numcig,lb_predicted, type='l',lty=3) 
lines(numcig,ub_predicted, type='l',lty=3) 
lines(numcig,predicted, type='l',lwd=2) 
lines(numcig,predicted_lin,col="black",lty=5) 
legend(28,4.4, c("Linear model", "Fractional polynomials"), 
col=c("black","black"),lty=c(5,1),lwd=c(1,2),bty="n") 
 
3. SAS programs for analysis of the 2 stage method: first step 
 
/******************************************************************** 
MACRO TWO STEP 
dataset -> dataset to analyse 
studies -> macrovariable with the studies considered 
case_control -> outcome variable (va1 case/control) 
exposure -> exposure variable 
exp_ref_cat -> reference category 
strata -> strata variable (if I don't want to conduct a stratified 
analysis, put "") 
format_exp -> exposure variable format 
num_studies -> the number of the last study considered 
********************************************************************/ 
 
 
%macro twostep 
(dataset,studies,case_control,exposure,exp_ref_cat,strata,format_exp,
num_studies); 
 
ods trace on; 
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%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," ")));  
 
 %let stud=%scan(&studies,&nstudy," "); 
   
 %if &strata eq "" %then %do; 
 *** for each study a logistic regression is performed with its 
specific adjustment; 
 proc logistic data=&dataset ; 
  title "Study &stud."; 
  format &exposure ; 
  class &exposure (ref="&exp_ref_cat") &&study&stud / param=ref; 
  model &case_control= &exposure &&study&stud ; 
  where va2=&stud; 
  ods output ParameterEstimates=beta_study&stud; /* output of beta 
estimates */ 
 run; 
 quit; 
 %end; 
 %else %do; 
 
 *** in strata of the strata variable; 
  proc sort data=&dataset;by &strata;run; 
  proc logistic data=&dataset ; 
  title "Study &stud."; 
  format &exposure ; 
  class &exposure (ref="&exp_ref_cat") &&study&stud / param=ref; 
  model &case_control= &exposure &&study&stud ; 
  by &strata; 
  where va2=&stud; 
  ods output ParameterEstimates=beta_study&stud; /* output of beta 
estimates */ 
 run; 
 quit; 
 %end; 
 
 *** We created a dataset with the only variables we need for the 
pooled analysis; 
 data beta&stud; 
  set beta_study&stud; 
 
  study=&stud; 
 
  if variable eq "&exposure"; 
   
  &exposure=input(ClassVal0,best12.); 
  format &exposure &format_exp..; 
 
   label &exposure="&exposure"; 
 
   drop df WaldChiSq ProbChiSq variable ClassVal0; 
 run; 
 
 %if &strata eq "" %then %do; 
 proc freq data=&dataset noprint; 
  table &exposure * &case_control /out=freqs&stud; 
  where va2=&stud; 
 run; /* nota. The proc  freq allow to have the number of cases and 
controls in each strata in order to be used in the forest plot */ 
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 %end; 
 %else %do; 
 proc freq data=&dataset noprint; 
  table &exposure * &case_control /out=freqs&stud; 
  by &strata; 
  where va2=&stud; 
 run;  
 %end; 
 
 data freqs&stud; 
  set freqs&stud; 
 
  study=&stud; 
 
  format &exposure &format_exp..; 
 run; 
 
%if &strata eq "" %then %do; 
proc sort data=freqs&stud;by study &exposure;run; 
 proc transpose data=freqs&stud out=t_freq&stud (drop=_NAME_ _LABEL_ 
rename=(COL1=CASES COL2=CONTROLS)); 
  var count; 
  by study &exposure; 
  where &exposure ne .a and &exposure ne .c ; 
 run; 
%end; 
%else %do; 
 proc sort data=freqs&stud;by study &exposure &strata;run; 
 proc transpose data=freqs&stud out=t_freq&stud (drop=_NAME_ _LABEL_ 
rename=(COL1=CASES COL2=CONTROLS)); 
  var count; 
  by study &exposure &strata; 
  where &exposure ne .a and &exposure ne .c ; 
 run; 
%end; 
 
  
 %let nstudy=%eval(&nstudy+1); 
 
%end; 
 
ods trace off; 
 
data beta_all_studies; 
 set  
  
 %let nstudy=1; 
 %do %while (%length(%scan(&studies,&nstudy," ")));  
 
 %let stud=%scan(&studies,&nstudy," "); 
   beta&stud  
 
   %let nstudy=%eval(&nstudy+1); 
 %end; 
 ; 
 
run; 
 
data freqs_all_studies; 
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 set 
 
 %let nstudy=1; 
 %do %while (%length(%scan(&studies,&nstudy," ")));  
 %let stud=%scan(&studies,&nstudy," "); 
   
 
   t_freq&stud  
   
 %let nstudy=%eval(&nstudy+1); 
 %end; 
 
 ; 
 
  where study ne . and (CASES ne . AND CONTROLS ne .); 
run; 
 
proc datasets lib=work nolist; 
 delete Beta_study1-Beta_study&num_studies Beta1-Beta&num_studies 
freqs1-freqs&num_studies t_freq1-t_freq&num_studies; 
quit; 
 
%if &strata eq "" %then %do; 
proc sort data=beta_all_studies;by study &exposure;run; 
proc sort data=freqs_all_studies;by study &exposure;run; 
 
data &exposure; 
 merge beta_all_studies (in=a) freqs_all_studies (in=b) ; 
 if a and b; 
 by study &exposure; 
 format study $studyb.; 
run; 
 
 
 
PROC EXPORT DATA= &exposure 
            OUTFILE= "&dir.&exposure..csv" 
            DBMS=CSV REPLACE; 
RUN; 
 
%end; 
%else %do; 
proc sort data=beta_all_studies;by study &exposure &strata;run; 
proc sort data=freqs_all_studies;by study &exposure &strata;run; 
 
data &exposure._&strata; 
 merge beta_all_studies (in=a) freqs_all_studies (in=b); 
 if a and b; 
 by study &exposure &strata; 
 format study $study.; 
run; 
 
PROC EXPORT DATA= &exposure._&strata 
            OUTFILE= "&dir.&Exposure._&strata..csv" 
            DBMS=CSV REPLACE; 
RUN; 
 
%end;%mend; 
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/******************************************************************** 
MACRO TWO STEP to alyse the TREND 
dataset -> dataset to analyse 
studies -> macrovariable with the studies considered 
case_control -> outcome variable (va1 case/control) 
exposure -> exposure variable 
exp_ref_cat -> reference category 
strata -> strata variable (if I don't want to conduct a stratified 
analysis, put "") 
format_exp -> exposure variable format 
num_studies -> the number of the last study considered 
********************************************************************/ 
 
 
%macro twosteptr 
(dataset,studies,case_control,exposure,exp_ref_cat,strata,format_exp,
num_studies); 
 
ods trace on; 
 
%let nstudy=1; 
%do %while (%length(%scan(&studies,&nstudy," ")));  
 
 %let stud=%scan(&studies,&nstudy," "); 
   
 %if &strata eq "" %then %do; 
 proc logistic data=&dataset ; 
  title "Study &stud."; 
  format &exposure ; 
  class /*&exposure (ref="&exp_ref_cat")*/ &&study&stud / param=ref; 
  model &case_control= &exposure &&study&stud ; 
  where va2=&stud; 
  ods output ParameterEstimates=beta_study&stud; /* output of beta 
estimates */ 
 run; 
 quit; 
 %end; 
 %else %do; 
  proc sort data=&dataset;by &strata;run; 
  proc logistic data=&dataset ; 
  title "Study &stud."; 
  format &exposure ; 
  class /*&exposure (ref="&exp_ref_cat")*/ &&study&stud / param=ref; 
  model &case_control= &exposure &&study&stud ; 
  by &strata; 
  where va2=&stud; 
  ods output ParameterEstimates=beta_study&stud; /* output of beta 
estimates */ 
 run; 
 quit; 
 %end; 
 
 data beta&stud; 
  set beta_study&stud; 
 
  study=&stud; 
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  if variable eq "&exposure"; 
   
  &exposure=input(ClassVal0,best12.); 
  format &exposure &format_exp..; 
 
   label &exposure="&exposure"; 
 
   drop df WaldChiSq ProbChiSq variable ClassVal0; 
 run; 
 
 %if &strata eq "" %then %do; 
 proc freq data=&dataset noprint; 
  table /*&exposure **/ &case_control /out=freqs&stud; 
  where va2=&stud and &exposure ne .; 
 run; /* nota. La proc freq mi serve per tabulare numero di casi e 
controlli entro ogni strato per il forest plot */ 
 %end; 
 %else %do; 
 proc freq data=&dataset noprint; 
  table /* &exposure **/ &case_control /out=freqs&stud; 
  by &strata; 
  where va2=&stud and &exposure ne .; 
 run;  
 %end; 
 
 data freqs&stud; 
  set freqs&stud; 
 
  study=&stud; 
 
  format &exposure &format_exp..; 
 run; 
 
%if &strata eq "" %then %do; 
proc sort data=freqs&stud;by study &exposure;run; 
 proc transpose data=freqs&stud out=t_freq&stud (drop=_NAME_ _LABEL_ 
rename=(COL1=CASES COL2=CONTROLS)); 
  var count; 
  by study &exposure; 
  where &exposure ne .a and &exposure ne .c ; 
 run; 
%end; 
%else %do; 
 proc sort data=freqs&stud;by study &exposure &strata;run; 
 proc transpose data=freqs&stud out=t_freq&stud (drop=_NAME_ _LABEL_ 
rename=(COL1=CASES COL2=CONTROLS)); 
  var count; 
  by study &exposure &strata; 
  where &exposure ne .a and &exposure ne .c ; 
 run; 
%end; 
 
  
 %let nstudy=%eval(&nstudy+1); 
 
%end; 
 
ods trace off; 
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data beta_all_studies; 
 set  
  
 %let nstudy=1; 
 %do %while (%length(%scan(&studies,&nstudy," ")));  
 
 %let stud=%scan(&studies,&nstudy," "); 
    
   beta&stud  
 
 %let nstudy=%eval(&nstudy+1); 
 %end; 
 
 ; 
 
run; 
 
data freqs_all_studies; 
 set 
 
 %let nstudy=1; 
 %do %while (%length(%scan(&studies,&nstudy," ")));  
 %let stud=%scan(&studies,&nstudy," "); 
   
   
   t_freq&stud  
   
%let nstudy=%eval(&nstudy+1); 
 %end; 
 
 ; 
 
  where study ne . and (CASES ne . AND CONTROLS ne .); 
run; 
 
proc datasets lib=work nolist; 
 delete Beta_study1-Beta_study&num_studies Beta1-Beta&num_studies 
freqs1-freqs&num_studies t_freq1-t_freq&num_studies; 
quit; 
 
 
%if &strata eq "" %then %do; 
proc sort data=beta_all_studies;by study &exposure;run; 
proc sort data=freqs_all_studies;by study &exposure;run; 
 
data &exposure; 
 merge beta_all_studies (in=a) freqs_all_studies (in=b); 
 if a and b; 
 by study &exposure; 
 format study $study.; 
run; 
 
PROC EXPORT DATA= &exposure 
            OUTFILE= "&dir.&exposure.tr.csv" 
            DBMS=CSV REPLACE; 
RUN; 
 
%end; 
%else %do; 
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proc sort data=beta_all_studies;by study &exposure &strata;run; 
proc sort data=freqs_all_studies;by study &exposure &strata;run; 
 
data &exposure._&strata; 
 merge beta_all_studies (in=a) freqs_all_studies (in=b); 
 if a and b; 
 by study &exposure &strata; 
 format study $study.; 
run; 
 
PROC EXPORT DATA= &exposure._&strata 
            OUTFILE= "&dir.&Exposure._&strata.tr.csv" 
            DBMS=CSV REPLACE; 
RUN; 
 
%end; 
 
%mend; 
 
4. R programs for analysis of the 2 stage method: second step 
 
 
cigday<-read.csv(file="F:\\DOTTORATO\\RELAZIONE TERZO 
ANNO\\SAS\\SMOKING\\DATASETS FOR R\\cigarette_dayarea.csv") 
attach(cigday) 
 
library(meta) 
# cigday 
# 1="Never smoker" 
# 2="Former cigarette smoker" 
# 3="0 to 10" 
# 4="11 to 20" 
# 5="> 20" 
# 6="Other than cigarette smoker"; 
 
# ALL STRATA INTO ONE GRAPH 
me<-metagen(TE=Estimate[cigarette_day!="Never smoker"], 
seTE=StdErr[cigarette_day!="Never smoker"], studlab=study[cigarette_day!="Never 
smoker"], sm="OR",n.e=CASES[cigarette_day!="Never smoker"], 
n.c=CONTROLS[cigarette_day!="Never smoker"], 
byvar=cigarette_day[cigarette_day!="Never smoker"],level=0.95,level.comb=0.95, 
comb.random=TRUE,comb.fixed=FALSE,method.tau="DL") 
 
setwd("F:\\DOTTORATO\\RELAZIONE TERZO ANNO\\RESULTS\\Smoking 
forest plot pdf\\") 
pdf(file="cigarette_day.pdf",paper = "a4", width = 11, height = 11,pagecentre=T, 
pointsize=7) 
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forest.meta(me,pooled.totals=FALSE,pooled.events=TRUE,smlab="",xlab="Odds 
Ratio",ref=1,overall=TRUE,print.I2=T,leftlabs=c("Study","Cancer 
cases","Controls","OR","95% CI"),xlim=c(0.25,4),col.square="black",col.by="black", 
addspace=TRUE,print.tau2=FALSE,rightcols=FALSE,leftcols=c("studlab","n.e","n.c"
,"effect","ci"),print.byvar=FALSE,text.random="Pooled estimate", 
ff.random.labels=0.5,ff.random=0.5,ff.hetstat=0.5,fontsize=8,squaresize=1) 
dev.off() 
 
 
# Subset: Former cigarette smoker 
 
me<-metagen(TE=Estimate[cigarette_day=="Former cigarette smoker"], 
seTE=StdErr[cigarette_day=="Former cigarette smoker"], 
studlab=study[cigarette_day=="Former cigarette smoker"], sm="OR", 
n.e=CASES[cigarette_day=="Former cigarette smoker"], 
n.c=CONTROLS[cigarette_day=="Former cigarette smoker"], 
byvar=area[cigarette_day=="Former cigarette smoker"], level=0.95,level.comb=0.95, 
comb.random=TRUE,comb.fixed=FALSE,method.tau="DL", title="Former cigarette 
smoker") 
 
setwd("F:\\DOTTORATO\\RELAZIONE TERZO ANNO\\RESULTS\\Smoking 
forest plot pdf\\") 
pdf(file="cigarette_day 1- Former cigarette smokertry.pdf", paper = "a4r",  width = 10,  
height = 10, pagecentre=T,  pointsize=10) 
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T, leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), print.byvar=F, col.square="black", 
col.by="black", addspace=TRUE, print.tau2=FALSE, rightcols=FALSE, 
leftcols=c("studlab", "n.e", "n.c", "effect", "ci"), text.random="Pooled estimate", 
ff.random.labels=2, sortvar=me$studlab, ff.random=1, ff.hetstat=1, fontsize=11, 
squaresize=1) 
dev.off() 
tiff(filename = "F:\\DOTTORATO\\RELAZIONE TERZO 
ANNO\\RESULTS\\Smoking forest plot tiff\\cigarette_day 1- Former cigarette 
smokerAREA.tiff",   width = 230,  height = 230,  units = "mm",  res=300) 
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T,  leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), print.byvar=F,  col.square="black", 
col.by="black", addspace=TRUE, print.tau2=FALSE, rightcols=FALSE,  
leftcols=c("studlab", "n.e", "n.c", "effect", "ci"), text.random="Pooled estimate", 
ff.random.labels=2, sortvar=me$studlab,  ff.random=1, ff.hetstat=1, fontsize=11, 
squaresize=1) 
dev.off() 
 
# Subset: 0 to 10  
 
me<-metagen(TE=Estimate[cigarette_day=="0 to 10"], 
seTE=StdErr[cigarette_day=="0 to 10"], studlab=study[cigarette_day=="0 to 10"],  
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sm="OR", n.e=CASES[cigarette_day=="0 to 10"], 
n.c=CONTROLS[cigarette_day=="0 to 10"], byvar=area[cigarette_day=="0 to 10"],  
level=0.95, level.comb=0.95, comb.random=TRUE, comb.fixed=FALSE, 
method.tau="DL", title="0 to 10") 
 
setwd("F:\\DOTTORATO\\RELAZIONE TERZO ANNO\\RESULTS\\Smoking 
forest plot pdf\\") 
pdf(file="cigarette_day 2- 0 to 10.pdf", paper = "a4r",  width = 10,  height = 10, 
pagecentre=T,  pointsize=10) 
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T, leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), print.byvar=F, col.square="black", 
col.by="black", addspace=TRUE, print.tau2=FALSE, rightcols=FALSE, 
leftcols=c("studlab", "n.e", "n.c", "effect", "ci"), text.random="Pooled estimate", 
ff.random.labels=2, ff.random=1, ff.hetstat=1, fontsize=11, squaresize=1) 
dev.off() 
 
tiff(filename = "F:\\DOTTORATO\\RELAZIONE TERZO 
ANNO\\RESULTS\\Smoking forest plot tiff\\cigarette_day 2- 0 to 10AREA.tiff",   
width = 230,  height = 230,  units = "mm",  res=300) 
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T, leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), print.byvar=F, col.square="black", 
col.by="black", addspace=TRUE, print.tau2=FALSE, rightcols=FALSE, 
leftcols=c("studlab", "n.e", "n.c", "effect", "ci"), text.random="Pooled estimate", 
ff.random.labels=2, ff.random=1, ff.hetstat=1, fontsize=11, squaresize=1) 
dev.off() 
 
# Subset: 11 to 20  
 
me<-metagen(TE=Estimate[cigarette_day=="11 to 20"], 
seTE=StdErr[cigarette_day=="11 to 20"], studlab=study[cigarette_day=="11 to 20"], 
sm="OR", n.e=CASES[cigarette_day=="11 to 20"], 
n.c=CONTROLS[cigarette_day=="11 to 20"], byvar=area[cigarette_day=="11 to 20"], 
level=0.95, level.comb=0.95, comb.random=TRUE, comb.fixed=FALSE, 
method.tau="DL", title="11 to 20") 
 
setwd("F:\\DOTTORATO\\RELAZIONE TERZO ANNO\\RESULTS\\Smoking 
forest plot pdf\\") 
pdf(file="cigarette_day 3- 11 to 20.pdf", paper = "a4r",  width = 10,  height = 10, 
pagecentre=T,  pointsize=10) 
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T, leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), print.byvar=F, col.square="black", 
col.by="black", addspace=TRUE, print.tau2=FALSE, rightcols=FALSE,  
leftcols=c("studlab", "n.e", "n.c", "effect", "ci"), text.random="Pooled estimate", 
ff.random.labels=2,  ff.random=1, ff.hetstat=1, fontsize=11, squaresize=1) 
dev.off() 
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tiff(filename = "F:\\DOTTORATO\\RELAZIONE TERZO 
ANNO\\RESULTS\\Smoking forest plot tiff\\cigarette_day 3- 11 to 20AREA.tiff",   
width = 230,  height = 230,  units = "mm",  res=300) 
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T,  leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), print.byvar=F, col.square="black", 
col.by="black", addspace=TRUE, print.tau2=FALSE, rightcols=FALSE,   
leftcols=c("studlab", "n.e", "n.c", "effect", "ci"), text.random="Pooled estimate", 
ff.random.labels=2, sortvar=me$studlab, ff.random=1, ff.hetstat=1, fontsize=11, 
squaresize=1) 
dev.off() 
 
# Subset: > 20  
me<-metagen(TE=Estimate[cigarette_day=="> 20"], seTE=StdErr[cigarette_day=="> 
20"], studlab=study[cigarette_day=="> 20"],  sm="OR", 
n.e=CASES[cigarette_day=="> 20"], n.c=CONTROLS[cigarette_day=="> 20"], 
byvar=area[cigarette_day=="> 20"], level=0.95, level.comb=0.95, 
comb.random=TRUE, comb.fixed=FALSE, method.tau="DL", title="> 20") 
 
setwd("F:\\DOTTORATO\\RELAZIONE TERZO ANNO\\RESULTS\\Smoking 
forest plot pdf\\") 
pdf(file="cigarette_day 4- up 20.pdf", paper = "a4r",  width = 10,  height = 10, 
pagecentre=T,  pointsize=10)  
forest.meta(me, pooled.totals=TRUE, pooled.events=TRUE, smlab=" ", xlab="Odds 
Ratio", ref=1, overall=TRUE, print.I2=T, leftlabs=c("Study", "Cancer cases", 
"Controls", "OR", "95% CI"), xlim=c(0.25, 4), col.square="black", col.by="black", 
addspace=TRUE, print.tau2=FALSE, rightcols=FALSE, leftcols=c("studlab", "n.e", 
"n.c", "effect", "ci"), text.random="Pooled estimate", ff.random.labels=2, 
ff.random=1,ff.hetstat=1,fontsize=11,squaresize=1) 
dev.off() 
 
tiff(filename = "F:\\DOTTORATO\\RELAZIONE TERZO 
ANNO\\RESULTS\\Smoking forest plot tiff\\cigarette_day 4- up 20AREA.tiff",  
width = 230, height = 230, units = "mm", res=300) 
forest.meta(me,pooled.totals=TRUE,pooled.events=TRUE,smlab=" ",xlab="Odds 
Ratio",ref=1,overall=TRUE,print.I2=T, leftlabs=c("Study","Cancer 
cases","Controls","OR","95% CI"),xlim=c(0.25,4),print.byvar=F, 
col.square="black",col.by="black",addspace=TRUE,print.tau2=FALSE,rightcols=FA
LSE, leftcols=c("studlab","n.e","n.c","effect","ci"),text.random="Pooled 
estimate",ff.random.labels=2,sortvar=me$studlab,ff.random=1,ff.hetstat=1,fontsize=1
1,squaresize=1) 
dev.off() 
 
 
